Please, recommend our website to your friends in Australia and USA and you’ll get an extra discount for Levitra levitra online australia Erectile dysfunction will never be a problem again. Browse our website to find the necessary impotence treatment in the required dose.

Microsoft word - suzanne mcdiarmid.doc

CURRICULUM VITAE
Suzanne Valerie McDiarmid, M.B., Ch.B. Business Address UCLA Medical Center, Room 12-383 MDCC 10833 Le Conte Ave, Los Angeles, CA 90095 Date of Birth: Place of Birth: Ashburton, New Zealand Education: 1976 Medical School of the University of Otago, Dunedin, New Zealand Postgraduate Training
1977
Junior House Surgeon, Dunedin, New Zealand Three months rotations in each of the following: Cardiac Surgery, General Surgery, Pediatrics, General Medicine. Senior House Surgeon, Dunedin, New Zealand. Three month rotations in each of the following: Radiotherapy, Emergency Room, General Medicine, General Surgery. One month as relieving Registrar in Emergency Room. Pediatric Resident, Eastern Virginia School of Medicine at the Children's Hospital of the King's Daughters. Chief Resident Pediatrics Valley Medical Center, Fresno, California Pediatric Gastroenterology Fellowship, UCLA Medical Center.

Licensure
New Zealand (1976-1979) Virginia (1979-1982) California, A39160 (1982-present)
Certification
1978
Passed E.C.F.M.G. (#302-577-2) Passed FLEX in Virginia Passed Written Exam of the American Board of Pediatrics Passed Oral Exam of the American Board of Pediatrics, May 1984 (#49423) Board Certified in Pediatric Gastroenterology Board Re-certified in Pediatric Gastroenterology 2006 Board Re-Certified in Pediatric Gastroenterology 2014 Board Re-Certified in Pediatric Gastroenterology
Memberships
1985
Junior Fellow - American Academy of Pediatrics American Society of Transplant Physicians Australia and New Zealand Transplant Society Fellow, American Academy of Pediatrics The Transplantation Society International Liver Transplant Society American Association for the Study of Liver Disease International Pediatric Transplantation Association American Society of Transplant Surgeons American Society of Reconstructive Transplantation
Professional Experience
Jan. 1977-Dec. 1978
House Surgeon at the Otago Hospital in Dunedin, New Zealand Jan. 1979-Mar. 1979 Registrar in Emergency Medicine, Otago Hospital, Dunedin, New Zealand Volunteer Physician, Public Health Services, Alaska Native Medical Center Private Practice in Pediatrics, Fresno, California Volunteer Physician, Murambinda Hospital, Zimbabwe
Hospital Appointments
July 1983-1985
Director of Pediatric Inpatient Service, Valley Medical Center, Fresno, California Los Angeles County Olive View - UCLA Medical Center. Sylmar, California January 1994 - present Director, Pediatric Liver Transplant Program, UCLA January 1995 - 2001 Director, Pediatric Liver Transplant Program, UCLA-Cedars-Sinai Medical Center September 2008 – present Medical Staff, Santa Monica-UCLA Hospital January 2012 – present Division Chief, Pediatric Gastroenterology, Hepatology and Nutrition, Mattel Children's Hospital UCLA
Faculty Appointments
July 1983-1984
Clinical Instructor, UCSF, San Francisco, California July 1988-June 89 Clinical Instructor, UCLA, Los Angeles, California July 89-June 90 Visiting Assistant Professor, UCLA, Los Angeles, California Assistant Professor of Pediatrics, UCLA, Los Angeles, California Associate Professor of Pediatrics and Surgery, UCLA, Los Angeles, California July 2000-present Professor of Pediatrics and Surgery, UCLA, Los Angeles, California
Committee Memberships - UCLA

Period of Service Medical School Admissions Committee 1992 - present U.C.L.A., School of Medicine 2. Editorial Committee for "Pediatric Update" Peer Review Committee U.C.L.A. School of Medicine 1994 - 1996 Quality Assurance Committee, Department of Pediatrics U.C.L.A., School of Medicine 1992 - 1997 Surgical and Invasive Procedures Committee U.C.L.A. School of Medicine 1997- 1999 6. Collins 5 year Review Committee 1997 Board member, Department of Pediatrics Group Practice U.C.L.A. School of Medicine. 1995 - 1999. Practice Plan Review Committee, Department of Pediatrics U.C.L.A. School of Medicine. 1995 - 1999. 9. Pediatrics Task Force, Operations Excellence 1992 – 1996 10 Ad Hoc Review Committees:UCLA Council 2000-2002 0n Academic Personnel Search Committee: Department of Surgery, UCLA 2001 Goldwyn Endowed Chair in Immunobiology and Transplantation Search Committee: Department of Surgery, UCLA 2005 Division Chief General Surgery 13. Braun 5 year Review Committee 2004 14. Busuttil 5 year Review Committee 2005 15. Search Committee: Department of Surgery, UCLA 2007 The Day Endowed Chair in Transplantation Surgery 16. Search Committee: Department of Surgery, UCLA 2007 Assistant Professor of Surgery, Division of Liver and Pancreas Transplantation 17. Search Committee Dept of Pediatrics: Division Chief, 2011 Nephrology Search Committee Dept of Surgery: Division Chief 2011 Pediatric Surgery 19. Dept of Pediatrics M and M Committee Search Committee Dept of Pediatrics: Vice Chair for Clinical Research 21. Search Committee Dept of Pediatrics: Chief of Critical Care Admissions Oversight Committee Board Memberships, Committees, Presidency – Extramural

1. Executive Organizing Committee for 1992 Transplant Games American Society of Transplantation: (I) Committee for Liver-Intra-abdominal Organ Transplantation 1993-2000 Co-Chair 1993, and 1996. (II) Pediatric Committee 1993 - 1996 (III) Councillor-at-large ASTP Board of Directors 1994 - 1997 (IV) Section Editor: ASTP Primer on Transplantation (V) Developmental Committee 1997 – present Co-Chair 2001-2002 (VI) Program and Publications Committee 1997 - 2000 (VII) Education Committee 1997 – 2000 Co-Chair 2000 (VIII) Scientific Studies Committee 1997 – 2000 (VIIII) Nominating Committee 2002 Federal Drug Administration. Member of Antiviral Drugs Advisory Committtee; Subcommittee on Immunosuppressive Drugs. Appointed 1995 United States Pharmacopeia Convention Inc Member of Transplant Immunology Advisory Panel, 1996 - 2000. International Liver Transplant Society Council Member, 1996 - 2009 President Elect 2003 President 2004 – 2005 Past President 2005 – 2006 Scope Committee 2006-2010 Chair, Development Committee 2004 – 2005 Chair Pediatric Committee 2007 - present American Association for the Study of Liver Disease Member, Publications Committee 2000 - 2002 Studies in Pediatric Liver Transplantation: A North American and Canadian Pediatric Liver Transplant Registry Scientific Advisory Board: - Co-chair 1995-2002 - Chair: 2002- 2006 - Council Member 2006 - present Chair, Development Committee 2000- present Grant Steering Committee, Co-Chair 2000 - 2006 Member 2006 –2011 8. United Network Organ Sharing (UNOS)
Immediate Past President: 2007 – 2008
President: 2006 - 2007
President Elect 2005 - 2006 Chair, Memborship and Professional Standards Committee 2005 (I) Pediatric Committee 1994 - 1996; Vice Chair 1996 - 1997; Chair 1998-2000. Exoffico 2000-2002 (II) Membership and Professional Standards Committee 1998-2000 (III) Combined Pediatric and Liver Intestinal Subcommittee for split liver, and pediatric donor policies. 1999-2000 (IV) Liver –Intestinal Committee for End-stage liver disease severity score. (V)Advisory Council for Pediatric Critical Pathway for Donor Management 2002 (VI) Data Working Group 2001-2004 (VII) Liver Intestinal Committee: 2004-2005 Chair, Vascularized Composite Tissue Allograft Committee. 2014 9. Coalition on Organ Donation. Board Member 2002-2004 10. Scientific Registry for Transplant Recipients. Member of Scientific Advisory Committee 2001- 2006 Post Transplant Tumor Registry Technical Advisory Committee 2001- 2006 Chair: 2004 – 2005 11. Painted Turtle Camp: Medical Executive Advisory Board 2003-2007 Medical Executive Committee 2007-present 12. Roche National Liver Advisory Board 2002 - 2006 13. International Conference on Immunosuppression: Liver Editorial Board 2003- 04 14. Amercian Society of Reconstructive Transplantation Co-Chair: Donor Legislation Committee 2010 – 2012 Board Member 2010 – 2012 Treasurer 2012-2014 President-Elect 2014 15. International Pediatric Transplantation Association: Member of Outreach Committee 2009-2011 16. Advisory Committee on Organ Transplantation to Secretary of Health 2013-present Editorial Services to Scholarly Publications

Associate Editor for Pediatric Transplantation 2001-2004 Associate Editor for Liver Transplantation 2000-2005 Editorial Board for Vascularized Composite Allotransplantation. 2014 Reviewer for Transplantation Reviewer for Journal of Pediatric Gastroenterology and Nutrition Reviewer for Pediatric Research Reviewer for Liver Transplantation Reviewer for Journal of Heart and Lung Transplantation Reviewer for Pediatric Transplantation Reviewer for Journal of Pediatrics Reviewer American Journal of Transplantation Reviewer for Transplant International Awards & Honors
1971
Awarded Junior University Scholarship. A National Examination for final year high school students. Won direct entry from high school into second year at the Medical School of the University of Otago in Dunedin, New Zealand. Awarded M.B., Ch.B. with Distinction. Awarded prize in Ob Gyn. Young Investigators Award. American Society of Transplantation Physicians. U.C.L.A. Department of Pediatrics Faculty Scholar Award from Philoptohos Society. Exceptional Service Award. National Kidney Foundation of Southern California. 2004 American Liver Foundation, Greater Los Angeles Chapter Medical Honoree of the Year Clinical Science Established Investigator Award, American Society of Transplantation Transplantation Society Recipient of the Arnold Silverman MD Lectureship
Research Grants: ( Since 2012 Last Review)

Title % Effort Dates Direct Costs

NIH 1 UO1 AI 104342-01
$14,000/yr
RFA-AI-12-005 Clinical Trials in
Transplantation in Children
Biomarkers for Post-Transplant
Lymphoproliferative
Disorders in Children
Role: UCLA Site Co-PI (Site PI:
R.Venick M.D.)
PI: Carlos Esquivel, M.D., Stanford

Medication Adherence in Children
12/1/09 - 6/30/2015
who had a Liver Transplantation
(MALT)
Co-PI with R Venick, M.D.
PI: E Shaymesh PhD. Mt Sinai
American Association for the Study of 10%

07/01/2012 – 6/30/2014 $90,000
Liver Diseases Career Development
Award in Liver Transplantation
(Co-PI with L.Wozniak M.D.)

To identify immune profiles of tolerance
in pediatric liver transplant recipients

American Society for Clinical

07/01/2011 - 6/30/2012
Pharmacology and Therapeutics
Award (Co-PI with L. Wozniak M.D.)
To identify immune profiles of tolerance
in pediatric liver transplant recipients

Publications: Peer Reviewed
Hyman PE, McDiarmid SV, Napolitano JA, Tomomasa T. Antroduodenal motility
studies in children with chronic intestinal pseudo-obstruction. J Peds. 1988; 112:899-905.
Iwaki Y, Askizawa D, Cook H, Furn H, Takiff S, McDiarmid S, Terasaki P, et al. ABO
matching in liver transplantation. Transplantation Proceedings 1988;20(1):564.
McDiarmid SV, Ettenger RB, Fine RN, Busuttil RW, Ament ME. Glomerular filtration
rate decreases serially in longterm pediatric liver transplantation survivors treated with
cyclosporine A. Transplantation. 1989:47;314-317.
McDiarmid SV, Cook DJ, Mickey MR, Ament ME, Busuttil RW, Terasaki PL. The
development of a lymphocyte population with suppressor phenotype after successful liver
transplantation. Transplantation Proceedings. 1989:21;423-424.
Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Busuttil RW, et
al. Randomized prospective trial of OKT3for early prophylaxis of rejection after liver
transplantation. Transplantation. 1989:47;1:82-88. McDiarmid SV, Ettenger RB, Hawkins RA, Senguttvan P, Busuttil RW, Vargas J,
Berquist WE, Ament ME. The impairment of true glomerular filtration rate in long-term
cyclosporine a treated pediatric allograft recipients. Transplantation.1990:49;81-85.
McDiarmid SV, Terasaki P, et al. Low OKT3 serum levels correlate with failure of
OKT3 prophylaxis in liver transplant patients. Transplantation Proceedings.
1990:22;1774-1776.
Hall TR, McDiarmid SV, Grant EG, Boechat MI, Busuttil RW. False negative duplex
doppler studies in pediatric liver transplant recipients with hepatic artery thrombosis. Am
J Radiology
. 1990:154;573-575.
McDiarmid SV, Lewin K, Busuttil RW. OKT3 prophylaxis in liver transplantation.
Transplantation. (Letter to the Editor) 1990:49;1203-1204.
Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME. Prediction
of long-term linear growth following liver transplantation. Transplantation Proceedings.
1990;22:1558-1559.
Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, and Ament ME. Effect
of nutritional status on outcome of orthotopic liver transplantation in pediatric patients.
Transplantation Proceedings. 1990;22:1560-1563.
Busuttil RW, Seu P, Millis JM, Olthoff KM, Hiatt JR, Milewicz A, Neusse B, El-Khoury
G, Raybould D, Nyerges A, Vargas J, McDiarmid S, Berquist W, Harrison R, Ament M.
Liver transplantation in children. Annals of Surgery. 1991;213:48-57.
McDiarmid SV, Hall TR, Grant EG, Milewicz AL, Olthoff KM, Lois JF, Ament ME,
Busuttil RW. Duplex Sonography fails to diagnose hepatic artery thrombosis in a high
risk group of pediatric liver transplant recipients. J Ped Surg. 1991;26(6):710-713.
McDiarmid SV, Busuttil RW, Levy P, Millis MJ, Terasaki P, Ament ME. The long term
outcome of OKT3 compared to cyclosporine prophylaxis after liver transplantation.
Transplantation. 1991;52:91-97.
McDiarmid SV, Klintmalm G, Busuttil R. FK506 Rescue therapy in liver
transplantation: Outcome and complications. Transplantation Proceedings.
1991;23:2996-2999.
McDiarmid SV, Gornbein JA, Fortunat M, Saikali D, Vargas JH, Busuttil RW, Ament
ME. Serum lipid abnormalities in pediatric liver transplant patients. Transplantation.
1992;53(1):109-115.
Colonna JO, Shaked A, Gomes AS, Coquhoun SD, Jurim O, McDiarmid SV, Millis MJ,
Goldstein LI, Busuttil RW. Biliary strictures complicating liver transplantatoin:
Incidence, pathogenesis, management. Ann Surg. 1992;216:344-352.
Moukarzel AA, Song MK, Buchman AL, Vargas J, Guss W, McDiarmid SV, Rayen L,
Ament ME. Excessive chromium intake in children receiving total parental nutrition.
Lancet 1992;339:385-388.
McDiarmid SV, Busuttil RW, Terasaki P, Vargas J Ament ME. OKT3 treatment of
steroid resistant rejection in pediatric liver transplant recipients. Journal of Pediatric
Gastroenterology and Nutrition
. 1992;14:86-91.
Shaked A, McDiarmid SV, Harrison R, Busuttil RW, Gelabert HA, Colonna JO. Gas
gangrene of the liver following orthotopic liver transplantation. Surgery.1992;111:462-
465.
Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS,
Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT, Tomlanovich SJ. RS-61443:
A multi-center study for refractory kidney transplant rejection. Ann Surg.
1992;216(4):513-519.
McDiarmid SV, Colonna JO, Shaked A, Vargas J, Ament ME, Busuttil RW.
Differences in oral FK506 dose requirements between adult and pediatric liver transplant
patients. Transplantation.1993;55:1328-1332.
Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R,
McDiarmid SV, Poplawski S, Sollinger H, Roberts J. RS-61443 for treatment-resistant
human liver rejection. Transplantation Proceedings. 1993;25:697.
Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB,
Stuart F, McDiarmid SV, Wall W.The OKT3 antibody response study (OARS):
Comparative testing of human anti-mouse antibody. Transplantation Proceedings.
1993;25:558-560.
Busuttil RW, Farmer DG, Shaked A, Rolandelli R, Colonna JO, Jurim O, Colquhoun SD,
Bertstein C, Shanahan F, Robert M, Goldstein LI, McDiarmid SV. Successful combined
liver and small intestine transplantation for short gut syndrome and liver failure. West J
Med
. 1993;158:184-188.
Egawa H, Shaked A, Konishi Y, McDiarmid SV, Vargas JH, Shimahara Y, Colonna JO,
Yamamoto N, Ozawa K, Busuttil RW. Arterial ketone body ratio in pediatric liver
transplantation. Transplantation.1993;55:522-526.
Farmer DG, McDiarmid SV, Kuniyoshi J, Robert ME, Shaked A, Busuttil RW.
Intragraft expression of interleukin-2 and interferon-gamma messenger RNA is a
predictor of rejection in rat small intestine allografts. Surgical Forum.1993;44:426-428.
McDiarmid SV, Klintmalm GB, Busuttil RW. FK506 conversion for intractable
rejection of the liver allograft. Transplantation International. 1993;6:305-312.
McDiarmid SV, Colonna JO, Vargas JH, Ament ME, Busuttil RW. A comparison of
renal function in cyclosporine and FK506 treated patients after primary orthotopic liver
transplantation. Transplantation. 1993;56:847-853.
Shaked A, Vargas J, Csete ME, Kiai K, Jurim O, Colquhoun S, McDiarmid SV, Ament
M, Busuttil RW. Diagnosis and treatment of bowel perforation following pediatric
orthotopic liver transplantation. Archives of Surgery. 1993;128:994-999.
US Multicenter FK 506 Liver Study Group: Klintman GB, Gonwa T, Wiesner RH,
Krom RAF, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, Busuttil RW,
McDiarmid S, Esquival CO, Nakazato P, Marsh JW, Woodle ES, Kalayoglu M,
D'Alessandro AM, Pirsch JD, Miller C, Schwartz M, Lewis WD, Monaco AP, Jenkins
RL, Emond JC, Thistlethwaite JR, Whitington PF, Steinmuller DR, Fitzsimmons WE,
Lawrence I. Use of FK 506 for the prevention of recurrent allograft rejection after
successful conversion from cyclosporine for refractory rejection. Transplantation
Proceedings.
1993;25:635-637.
US Multicenter FK 506 Liver Study Group: Klintmalm GB, Gonwa T, Wiesner RH,
Krom RAF, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, Busuttil RW,
McDiarmid S, Esquivel CO, Nakazato P, Marsh JW, Woodle ES, Kalayoglu M,
D'Alesandro AM, Pirsch JD, Miller C, Schwartz M, Lewis WD, Monaco AP, Jenkins
RL, Emond JC, Thistlethwaite JR, Whitington PF, Steinmuller DR, Fitzsimmons WE, Lawrence I. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. Transplantation Proceedings. 1993;25:641-643. US Multicenter FK 506 Liver Study Group: Klintmalm GB, Gonwa T, Wiesner RH,
Krom RAF, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, Busuttil RW,
McDiarmid S, Esquival CO, Nakazato P, Marsh JW, Woodle ES, Kalayoglu M,
D'Alessandro AM, Pirsch JD, Miller C, Schwartz M, Lewis WD, Monaco AP, Jenkins
RL, Emond JC, Thistlethwaite JR, Whitington PF, Steinmuller DR, Fitzsimmons WE,
Lawrence I. Use of FK 506 as rescue therapy for refractory rejection after liver
transplantation. Transplantation Proceedings.1993;25:679-688.
Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB,
Stuart F, McDiarmid SV, Wall W. OKT3 antibody response study (OARS): a
multicenter comparative study. Transplantation Proceedings. 1993;25:558-60.
Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS,
Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT, et al. RS-61443: rescue
therapy in refractory kidney transplant rejection.Transplantation Proceedings.
1993;25:698-699.
Farmer DG, McDiarmid SV, Kuniyoshi J, Robert ME, Shaked A, Busuttil RW.
Intragraft expression of messages RNA for interleukin-6 and tumor necrosis factor-alpha
is a predictor of rat small intestine transplant rejection. Journal of Surgical Research
1994;57:138-142.
Jurim O, Gelabert HA, McDiarmid SV, Millis MJ, Nuesse B, Shaked A, Busuttil RW.
The outcome of reduced-size grafts following emergency pediatric liver transplantation.
Transplantation Proceedings. 1994;26:195.
McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW. The treatment of
intractable rejection with FK506 in pediatric liver transplant recipients. Journal of
Pediatric Gastroenterology and Nutrition
1995;20:291-299.
Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR, Nuesse BJ,
Csete M, Goldstein LI, McDiarmid SV. One thousand liver transplants. The lesions
learned. Annuals of Surgery. 1994;219:490-499.
McDiarmid SV, Farmer DG, Kuniyoshi JJ, Robert M, Khadavi A, Shaked A, Busuttil
RW. Intragraft cytokine and cytotoxic T lymphocyte (CTL) specific protein expression
are predictors of rat small intestine transplant rejection. Transplantation Proceedings.
1994;26:1520-1521.
McDiarmid SV, Farmer DG, Kuniyoshi JJ, Robert M, Khadavi A, Shaked A, Busuttil
RW. The correlation of intragraft cytokine expression with rejection in rat small intestine
transplantation. Transplantation 1994;58:690-697.
McDiarmid SV, Farmer DG, Kuniyoshi JJ, Robert M, Khadavi A, Shaked A, Busuttil
RW. Perforin and Granzyme B: Cytolytic proteins upregulated during rejection of rat
small intestine allografts. Transplantation 1995;59:762-766.
McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro Am, Esquivel C,
Kalayoglu M, Klein AS, Marsh JW, Miller CM, Shaw BW, So SK. FK506 compared to
cyclosporine for primary immunosuppression after pediatric liver transplantation: results
from the U.S. multicenter trial. Transplantation 1995;59:530-536.
Jurim O, Shakelton CR, McDiarmid SV, Martin P, Shaked A, Millis JM, Imagawa DK,
Olthoff K, Maxfield A, Pakrasi AL, Melinek J, Ament ME, Vargas J, Goldstein LI,
Busuttil RW. Living-Donor Liver Transplantation at UCLA. The American Journal of
Surgery
1995;169:529-532.
Shackelton CR, Martin P, Melinek J, Stothers L, Millis JM, Olthoff KM, Imagawa DK,
Kinkhabwala M, Rudich S, Seu P, Shaked A, McDiarmid SV, Goldstein LI, Busuttil
RW. Lack of correlation between the magnitude of preservation injury and the incidence
of acute rejection, need for OKT3 or conversion to FK506 in cyclosporine treated
primary liver allograft recipients. Transplantation. 1995;60:554-558.
McDiarmid SV, Farmer DA, Goldstein LI, Martin P, Vargas J, Busuttil RW. A
randomized prospective trial of steroid withdrawal after liver transplantation.
Transplantation. 1995;60:1443-50.
Jurim O, Csete M, Gelabert HA, Millis JM, Olthoff KM, Imagawa DK, Shaked A,
McDiarmid SV, Busuttil RW. Reduced size grafts - The solution for hepatic artery
thrombosis after pediatric liver transplantation. J Pediatric Surgery. 1995;30(1): 53-55.
Shiraishi M, Csete M, Yasunaga C, McDiarmid SV, Vannice JL, Busuttil RW, Shaked
A. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments
cyclosporine immunosuppression in a rat cardiac allograft model. Journal of Surgical
Research.
1995;58(5):465-470.
Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB,
Stuart F, McDiarmid SV, Wall W. The OKT3 antibody response study: a multicenter
study of human anti-mouse antibody (HAMA) production following OKT3 use in solid
organ transplantation. Transplant Immunology. 1995;3(3):212-221.
McDiarmid SV, Blumberg DA, Remotti H, Vargas JH, Tipton JR, Ament ME, Busuttil
RW. Mycobacterial infections after pediatric liver transplantation. A report of 3 cases,
and review of the literature. Journal of Pediatric Gastroenterology and Nutrition.
1995;20:425-431.
Farmer DG, Shaked A, McDiarmid SV, Olthoff KM, Millis JM, Imagawa DK, Colonna
JO, Robert ME, Lewin K, Goldstein LI, et al. Small intestine transplantation at the
University of California, Los Angeles. Transplantation Proceedings.1996;25(5):2746-
2747.
Goss JA, Shakelton CR, Swenson K, Satou NL, Nuesse BJ, Imagawa DK, Kinkhabwala
MM, Seu P, Markowitz JS, Rudich SM, McDiarmid SV, Busuttil RW. Orthotopic liver
transplantation for congenital biliary atresia. An 11-year, single-center experience. Ann
Surg
.1999; 224(3):276-84
Rosen HR, O'Reilly PM, Shackleton Crigler-Najjar, McDiarmid SV, Holt C, Busuttil
RW, Martin P. Graft loss following liver transplantation in patients with chronic
hepatitis C. Transplantation. 1996;62:1773-1776.
Goss JA, Schiler GJ, Martin P, Seu P, McDiarmid SV, Shackelton CR, Markowitz JS,
Nuesse BJ, Goldstein LI, et al. Aplastic anemia complicating orthotopic liver
transplantation. Hepatology.1997;26(4):865-9.
Rosen HR, Shackelton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C,
Lewin KJ, Busuttil RW, Martin P. Use of OKT3 is associated with early and severe
recurrence of hepatitis C after liver transplantation. American Journal of
Gastroenterology
. 1997;92(9):1453-7.
Sher LS. Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil RW,
McDiarmid SV, Burdick JF, Klein AS, et all. Efficacy of tacrolimus as rescue therapy
for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter
Liver Study Group. Transplantation. 1997;64(2)258-63.
Dunn S, Cooney G, Sommerauer J, Lindsay C, McDiarmid SV, Wong RL, Chang CT,
Smith HT, Choc MG Jr. Pharmacokinetics of an oral solution of the microemulsion
formulation of cyclosporine in maintenance pediatric liver transplant recipients.
Transplantation. 1997;63(12):1762-7.
Rivera-Pinera T, Moreno J, Skaff C, McDiarmid SV, Vargas J, Ament ME. Delayed
encephalopathy in fulminant hepatic failure in the pediatric population and the role of
liver transplantation. Journal of Pediatric Gastroenterology and
Nutrition.1997;24(2):128-34.
Shackelton CR, Goss JA, Swenson K, Colquhoun SD, Seu P, Kinkhabwala MM, Rudich
SM, Markowitz JS, McDiarmid SV, Busuttil RW. The impact of microsurgical hepatic
arterial reconstruction on the outcome of liver transplantation for congenitalk biliary
atresia. American Journal of Surgery.1997;173(5):431-5.
O'Reilly PM, Rosen HR, Shackelton CR, McDiarmid SV, Holt C, Busuttil RW, Martin
P. Causes of graft loss following liver transplantation for chronic hepatitis C.
Transplantation Proceedings.1997;29(1-2):526-8.
Rivera-Pinera T, Gugig R, Davis J, McDiarmid SV, Vargas J, Rosenthal P, Berquist W,
Heyman MB, Ament ME. Outcome of acetaminophen overdose in pediatric patients and
factors contributing to hepatotoxicity. Journal of Pediatrics.1997;130(2):300-4.
Markmann JF, Markowitz JA, Yersiz H, Morrisey M, Farmer DG, Farmer DA, Goss J,
Ghobrial R, McDiarmid SV, Stribling R, Martin P, Goldstein LI, Seu P, Shackelton C,
Busuttil RW. Long-term survival following re-transplantation of the liver. Annals of
Surgery
. 1997;226(4):408-420.
Goss JA; Yersiz H; Shackelton CR; Seu P; Smith CV; Markowitz JS; Farmer DG;
Ghobrial RM; Markman JF; Arnaout WS; Imagawa DK; Colquhoun SD; Fraiman MH;
McDiarmid SV; Busuttil RW. In situ splitting of cadaveric liver for transplantation.
Transplantation. 1997;64(6): 871-7.
McDiarmid SV, Conrad A, Ament ME, Vargas JH, Martín MG, Goss JA, Busuttil RW.
De novo hepatitis C in children after liver transplantation. Transplantation. 1998;66:311-
8.
McDiarmid SV, Goss JA, Seo P, Shackelton C, Vargas JH, Ament ME, Busuttil RW.
100 Children treated with tacrolimus after primary orthotopic liver transplantation.
Transplant Proceedings. 1998;30: 1397-8.
Misra S, Moore TB, Ament ME, Busuttil RW, McDiarmid SV. Red cell aplasia in
children on tacrolimus after liver transplantation. Transplantation. 1998;65:575.
Goss JA; Shackelton CR; Maggard M; Swenson K; Seu P; McDiarmid SV; Busuttil
RW.Liver transplantation for fulminant hepatic failure in the pediatric patient. Archives
of
Surgery. 1998;133(8):839-46.
Chang RK; Alonza M; Alejos J; Jue K; McDiarmid SV. Marked left ventricular
hypertrophy in children tacrolimus (FK506) after orthotopic liver transplantation.
American Journal of Cardiology.1998;81(10):1277-80.
Farmer DG; McDiarmid SV; Smith C; Stribling R; Sue P; Ament MA; Vargas J;
Experience with combined liver-small intestine transplantation at the University of
California, Los Angeles. Transplantation Proceedings .1998;30(6):2533-4.
Goss JA; Shackleton CR; McDiarmid SV; Maggard M; Swenson K; Seu P; Vargas J;
Martin M; Ament M; Brill J; et al. Long term results of pediatric liver transplantation: an
analysis of 569 transplants.Annals of Surgery. 1998;228 (3): 411-20.
Woodle ES; Millis JM; So SK; McDiarmid SV; Busuttil RW; Esquivel CO; Whitington
PF; Thistlethwaite JR. Liver transplantation in the first three months of life.
Transplantation. 1998;66 (5):609-9.
Busuttil AA; Goss JA; Seu P; Dulkanchainun TS; Yanni GS; McDiarmid SV; Busuttil
RW. The role of orthotopic liver transplantation in the treatment of ornithine
transcarbamylase deficiency. Liver Transplantation and Surgery.1998;4(5):350-4.
McDiarmid SV; Jordon S; Lee GS; Toyoda M; Goss JA; Vargas JH; Martin MG; Bahar
R; Maxfield AL; Ament ME; Busuttil RW. Prevention and preemptive therapy of
postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation.
1999;67(3):404-11.
McDiarmid SV; Gornbein JA; DeSilva PJ; Goss JA; Vargas JH; Martin MG; Ament
ME; Busuttil RW.Factors affecting growth after pediatric liver transplantation.
Transplantation. 1999;67 (3):404-11.
Cooney GF; Dunn SP; Sommerauer J; Lindsay C; McDiarmid SV;Choc MG Jr; Smith
HT; Chang CT; Wong RL.Improved cyclosporine bioavailability in black pediatric liver
transplant recipients after administration of the microemulsion formulation. Liver
Transplantation and Surgery
.1999;5(2):112-8.
Otto MG; Mayer AD; Clavien PA; Cavallari A;Gunawardena KA; Mueller EA. On behalf of Multicenter International study in Liver Transplantation of Neoral Study Group. Randomized trial of cyclosporine micromulsion (Neoral) versus conventional cyclosporine in liver transplantation. Transplantation. 1998;66 (12):1632-1640. Busuttil AA; Goss JA; Seu P; Dulkanchinum TS; Yanni GS; McDiarmid SV; Busuttil
RW. The role of orthotopic liver transplantation in the treatment of ornithine
transcarbamy deficiency. Liver Transplantation and Surgery. 1998;4(5):350-4.
Younes BS; Ament ME; McDiarmid SV; Martin MG; Vargas JH. The involvment of the
gastrointestinal tract in posttranplant lymphoproliferative disease in pediatric liver
transplnatation. Journal of Pediatric Gastroenterology and Nutrition. 1999;28(4):380-5.
Quiros-Tejeira RE;Ament ME; Heyman MB; Martin MG; Rosenthal P; Hall TR;
McDiarmid SV; Vargas JH. Variable morbidity in alagille syndrome: a review of 43
cases. Journal of Pediatric Gastroenterology and Nutrition . 1999;29(4):431-7.
Maggard MA; Goss JA; Swenson KL; McDiarmid SV; Busuttill RW. Liver
tranplantation in polysplenia syndrome: use of living related donor. Transplantation.
1999;68(8):1206-9.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament
ME. The effect of immunosuppression on posttransplant lymphoproliferative disease in
pediatric liver transplant patients. Transplantation. 2000;70(1):94-9.
Ghobrial RM; Yersiz H; Farmer DG; Amersi F; Goss J; Chen P; Dawson S; Lerner S; Nissen N; Imagawa D; et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Annals of Surgery. 2000;232(3):312-23. Farmer DG; McDiarmid SV; Yersiz H; Cortina G; Restrepo GC; Amersi F; Vargas J;
Gershman G; Ament M; Reyen L; et al. Improved outcome after intestinal
transplantatation: an 8-year, single-center experience. Transplatation Proceedings.
2000;32(6):1233-4.
Quiros-Tejeira RE;Ament ME; Heyman MB; Martin MG; Gornbein JA; Rosenthal P;
McDiarmid SV; Vargas JH. Does liver transplantation affect growth pattern in Alagille
syndrome? Liver Transpl, 2000;6(5):582-7.
Misra S; Moore TB; Ament ME; Vargas JH; Busuttil RW; McDiarmid SV. Profile of
anemia in children after liver transplantation. Transplantation. 2000;70(9):1283-91.
Chang RKR; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS. Echocardiographic
findings of hupertrophic cardiomyopathy in children after orthotopic liver transplantation.
Pediatric Transplantation. 2001;5(3):187-91.
MacFarlane GD; Venkataramanan R; McDiarmid SV; Pirsch JD; Scheller DG;Ersfeld
DL; Fitzsimmons WE. Therapeutic drug monitoring of tacrolimus in pediatric liver
transplant patients. Pediatric Transplantation. 2001;5(2):119-24.
McDiarmid SV; Davies D; Edward E. Improved graft survival of pediatric liver
recipients transplanted with pediatric-aged liver donors. Transplantation.
2000;70(9):1283-91.
Cho AS; Holland GN; Glasgow BJ; Isenberg SJ; George BL; McDiarmid SV.Ocular
involvement in patients with posttransplant lymphoproliferative disorder.Arch
Ophthalmology
2001;119(2):183-9.
Bahar RJ; Yanni GS; Martin MG; McDiarmid SV; Vargas JH; Gershman GB;Heyman
MB; Rosenthal P; Tipton JR; Nanjundiah P; Starr A; Ament ME.Orthotopic liver
transplantation for autoimmune hepatitis and cryptogenic chronic hepatitis in children.
Transplantation 2001;72(5):829-33.
Farmer DG; McDiarmid SV; Yersiz H; Cortina G; Amersi F; Vargas J; Gershman G;
Ament M, Busuttil RW. Outcome after intestinal transplantation: results from one
center's 9-year experience; discussion 1031-2. Arch Surg. 2001;136(9) 1027-31.
Markmann JF; Markmann JW; Markmann DA; Bacquerizo A; Singer J; Holt CD;
Gornbein J; Yersiz H; Morrissey M; Lerner SM; McDiarmid SV; Busuttil RW.
Preoperative factors associated with outcome and their impact on resource use in 1148
consecutive primary liver transplants. Transplantation 2001;72(6):1113-22.
Weisner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK;
Krom RA; Kim WR. MELD and PELD: application of survival models to liver
Allocation. Liver Transplantation 2001;7(7):567-80
Farmer DG; Yersiz H; Ghobrial RM; McDiarmid SV; Gornbein J; Le H; Schlifke
A;Amersi F; Maxfield A; Amos N; Restrepo GC; Chen P; Dawson S 3rd ; Busuttil RW.
Early graft function after pediatric liver transplantation: comparison between in situ split
liver grafts and living-related liver grafts. Transplantation 2001;72(11):1795-802.
McDiarmid SV. Update from studies in pediatric liver transplanation. Transplant Proc
2001;33(7-8):3604-5
Wiesner R; Rabkin J; Klintmalm G; McDiarmid SV; Langnas A; Punch J; McMaster
P;Kalayoglu M; Levy G; Freeman R; Bismuth H; Neuhaus P; Memelok R; Wang W. A
randomized double-blind comparative study of mycophenolate mofetil and azathioprine
in combination with cyclosporine and corticosteroids in primary liver transplant
recipients. Liver Transplantation 2001;5:442-50.
Farmer DG; McDiarmid SV; Yersiz H; Cortina G; Vargas J; Maxfield AJ;
Vandenbogaart B;Correa M; Kroeber A; Geevarghese S; Busuttil RW. Outcomes after
intestinal transplantation: a single center experience over a decade. Transplant Proc
2002;34(3):896-7
Farmer DG; McDiarmid SV; Winston D; Yersiz H; Cortina G; Dry S; Maxfield AJ;
Vandenbogaart B; Correa M; Krober A; Geevarghese S; Busuttil RW. Effectiveness of
aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and
Epstein-Barr viral disease after human intestinal transplantation. Transplant Proc
2002;34(3)948-9
Farmer DG; Amersi F; Shen XD; Gao F; Anselmo D; Ma J; Dry S; McDiarmid SV;
Shaw G; Busuttil RW; Kupiec-Weglinski J. Improved survival through the reduction of
iscemia-reperfusion injury after rat intestinal transplantation using selective P-selectin
blockade with P-selectin glycoprotein ligand-Ig. Transplant Proc 2002;34(3):985

100. McDiarmid SV; Anand R; Lindblad AS. Development of a pediatric end-stage liver
disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74(2):173-81. 101. Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV;
Busuttil RW. Pretransplant model to predict posttransplant survival in liver transplant
Patients. Ann Surg 2002;6(3):315-22.
102. Quiros-Tejeira RE ; Ament ME ; McDiarmid SV ; Gonzalez M ; Chong R ; Vargas JH ;
Martin MG. Late-onset bacteremia in uncomplicated pediatric liver transplant recipients after a febrile episode. Transpl Int 2002;15(9-10):502-7.
103. Freeman RB Jr, Weisner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R,
Wolfe R, Turcotte J, Teperman L;UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Tranplantation Committes. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transplantation 2002; 8(9): 851-8.
104. Pacini-Edelstein SJ, Bahar RJ, McDiarmid SV, Vargas JH, Martin MG, Mehra M,
Ament ME. The unique occurrence of hepatic failure from type 1 autoimmune hepatitis with concurrent brain abscess. Journal Pediatric Gastroenterology 2003;36(3):414-7.
105. Farmer DG; Anselmo DM; Ghobrial RM; Yersiz H; McDiarmid SV; Cao C; Weaver M;
Figueroa J; Khan K; Saab S; Han S; Durazo F; Goldstein L; Holt C; Busuttil RW. Liver transplantation for fulminant hepatic failure: Experience with more than 200 patients over a 17-year period. Annals of Surgery. 2003;237(5):666-75.
106. Pacini-Edelstein SJ, Mehra M, Ament ME, Vargas JH, Martin MG, McDiarmid SV.
Varicella in pediatric liver transplant patients: a retrospective analysis of treatment and outcome. Journal Pediatric Gastroenterology Nutrition. 2003;37(2):183-6.
107. Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW. One
hundred in situ split-liver transplantations: a single-center experience. Annals of Surgery. 2003;238(4):496-505.
108. Chow EL, Cherry JD, Harrison R, McDiarmid SV, Bhuta S. Reassessing Reyes
syndrome. Arch Pediatric Adolesc Medicine. 2003;157(12):1241-2. 109. Carmody IC, Meng L, Shen XD, Anselmo D, Gao F, Ke B, Ma JP, Kupiec-Weglinski JW, McDiarmid SV, Busuttil RW, Shaw G, Farmer DG. P-Selectin knockout mice have
improved outcomes with both warm ischem and small bowel transplantation. Transplant
Proc.
2004;36(2):303-4.

110. Farmer DG, McDiarmid SV, Edelstein S, Yersiz H, Vargas J, Cortina G, Renz JF,
Fondevila C, Hisatake G, Reyen L, Correa M, Rhodes S, Zafar A, Chavez Y, Busuttil RW. Improved outcome after intestinal transplantation at a single institution over 12 years. Transplant Proc. 2004;36(2):303-4.
111. Renz JF, McDiarmid SV, Edelstein S, Yersiz H, Hisatake GM, Gordon S, Saggi BH,
Busuttil RW,Farmer DG. Application of combined liver-intestinal transplantation as a staged procedure. Transplant Proc. 2004;36(2):314-5.
112. Farmer DG, McDiarmid SV, Edelstein S, Renz JF, Hisatake G, Cortina G, Fondevila C,
Correa M, Rhodes S, Zafar A, Chavez Y, Yersiz H, Busuttil RW. Induction therapy with interleukin-2 recptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function. Transplant Proc. 2004;36(2):331-2.
113. Ziring D, Tran R, Edelstein S, McDiarmid SV, Vargas J, Cortina G, Gajjar N, Ching N,
Cherry J, Krogstad P, Renz JF, Fondevila C, Busuttil RW, Farmer DG. Infectious entertis afterintestinal transplantation: incidence, timing, and outcome. Transplant Proc. 2004;36(2):379-80.
114. Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM.
Improving liver allocation: MELD and PELD. Am Journal of Transplanation. 2004;4 Suppl 9:114-31.
115. McDiarmid SV, Anand R, Lindblad AS; SPLIT Research Group. Studies of Pediatric
Liver Transplantation:2002 update. An overview of demographics, in pediatric liver transplantation in the United States and Canada. Pediatric Transplantation. 2004;8(3)284-94.
116. Olthoff KM, Brown, RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM
Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. Liver Transplant 200410(10 Suppl 2):A6-22.
117. McDiarmid SV, Anand R; SPLIT Research Group. Studies of pediatric liver
transplantation (SPLIT): a summary of the 2003 Annual Report. Clin Transpl 2003;119-130. 118. Farmer DG, Shen XD, Amersi F, Anselmo D, Ma JP, Ke B, Gao F, Dry S, Fernandez S, Shaw GD, McDiarmid SV, Busuttil RW, Kupiec-Weglinski J. CD62 blockade with P-
selectin glycoprotine ligand-immunoglobulin fusion protein reduces ischemia-reperfusion
injury after rat intestinal transplantation. Transplantation 2005;79(1):44-51.

119. Ziring D, Tran R, Edelstein S, McDiarmid SV, Gajjar N, Cortina G, Vargas J, Renz JF,
Cherry JD, Krogstad P, Miller M, Busuttil RW, Farmer DG. Infectious enteritis after intestinal transplantation: incidence, timing and outcome. Transplantation 2005;79(6):702-709.
120. Quiros-Tejeira RE, Molina RA, Katzir L, Lie A, Vargas JH, Ament ME, McDiarmid
SV, Martin MG. Resolution of hypophosphatemia is associated with recovery of hepatic
function in children with fulminant hepatic failure. Transplant Int 2005;18(9):1061-
1066.

121. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S,
Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005;241(6):905-916.
122. Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, Magee JC, McDiarmid SV, Anand
R; The Split Research Group. Biliary atresia: clinical profiles, risk factors and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005;147(2):180-185.
123. Farmer DG, Anselmo D, Shen XD, Ke B, Carmody IC, Gao F, Lassman C, McDiarmid
SV, Shaw G, Busuttil RW, Kupiec-Weglinski JW. Disruption of P-selectin signaling
modulates cell trafficking and results in improved outcomes after mouse warm intestinal
ischemia and reperfusion injury. Transplantation 2005;80(6):828-835.

124. Lipshutz, GS., Patel, S., Hiatt, JR., Yersiz, H., Farmer, DG., McDiarmid, SV., Ghobrial,
RM., Busuttil, RW. Portocaval Hemitransposition in Pediatric Liver Transplant Recipients: A Single Center Experience. Liver Transplantation 2006;12:1097-103.
125. Venick RS, Farmer DG, Saikali D, Gordon S, Colangelo J, Reyen L, McDiarmid SV,
Vargas JH, Ament ME, Busuttil RW. Nutritional outcomes following pediatric intestinal transplantation. Transplant Proc 2006;38(6):1718-9.
126. Venick RS, McDiarmid SV, Farmer DG, Gornbein J, Martin MG, Vargas JH, Ament
ME, Busuttil RW. Rejection and steroid dependence: Unique risk factors in the development of posttransplant de novo autoimmune hepatitis. Am J Transplant 2007;7(4):955-63.
127. McDiarmid SV, Goodrich NP, Harper AM, Merion RM. Liver transplantation for status
1: the consequences of good intentions. Liver Transpl 2007;13(5):699-707.
128. McDiarmid SV, Merion RM, Dykstra DM, Harper AM., Use of a pediatric end-stage
liver disease score for deceased donor allocation United States experience. Indian J Pediatr 2007;74(4):387-92.
129. Farmer DG, Venick RS, McDiarmid SV, Ghobrial RM, Gordon SA, Yersiz H, Hong J,
Candell L, Cholakians A, Wozniak L, Martin M, Vargas J, Ament M, Hiatt J, Busuttil RW. Predictors of outcomes after pediatric liver transplantation: an analysis of cases performed at a single institution. J Am Coll Surg 2007;204(5):904-14;discission 914-6.
130. Wu SS, Chao CS, Vargas JH, Sharp HL, Martin MG, McDiarmid SV, Sinatra FR,
Ament ME. Isoniazid-related hepatic failure in children: a survey of liver transplantation. Transplantation 2007;84(2):173-9. 131. Hathout E, Alonso E, AnandR, MartzK, ImseisE, Johnston J, LopezJ, ChinnockR, McDiarmid S. Post transplant diabetes mellitus in pediatric liver transplantation. Pediatr
Transplant. 2007 Dec 30. Epub ahead of print.

132. Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV,
Anand R, Song C; SPLIT Research Group. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008;8(2):396-403.
133. Liu D, Gomes AS, McDiarmid SV. Successful treatment of isolated draining
intrahepatic biliary ducts in a post liver transplant recipient using alcohol sclerotherapy. J Vasc Interv Radiol 2008;19(3):121-3.
134. McDiarmid SV, Pruett TL, Graham WK. The Oversight of solid Organ Transplantation
in the United States. American Journal of Transplantation 2008;8(4): 739-744
135. Stuber ML, ShemeshE, SeacordD, Washington 3rd, Hellemann G, McDiarmid S.
Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant. 2008;12(3);284-288
136. Alonso EM, Neighbors K, Barton FB, McDiarmid SV, Dunn SP, Mazariegos GV,
Landgraf JM, Bucuvalas JC; Studies of Pediatric Liver Tranplant Study Group. Health-related quality of life and faily function following pediatric liver transplantation. Liver Transpl. 2008 14(4): 460-480
137. Kaldas F, Farmer D,Gordon,SA, McDiarmid SV, Venick, R Colangelo J, Busuttil RW.
Renal events in intestinal transplantation: results from a single-center. Transplant Proc. 2007;39(10)3387-3388 138. Watson MJ, Venick RS, Kaldas F, Rastogi A, Gordon SA, ColangeloJ, EsmailianY, McDiarmid SV, Busuttil RW, Farmer DG. Renal function impacts outcomes after
intestinal transplantation. Transplantation. 2008;86(1):117-122

139. McDiarmid SV, Cherick W, Sweet S. Preventable Deaths on the Pediatric Transplant
Waiting List. American Journal of Transplantation 2008;8(12):2491-5. Epub 2008 Oct 24.
140. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, McDiarmid S, Cohen
G, Anand R; Studies of Pediatric Liver Transplantation Research Group. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American multicenter registry. Pediatrics.2008 Dec;122(6):e1128-35.
141. Farmer DG, Venick RS, McDiarmid SV, Duffy JP, Kattan O, Hong JC, Vargas J, Yersiz
H, Busuttil RW. Fulminant hepatic failure in children: superior and durable outcomes with liver transplantation over 25 years at a single center. Ann Surg. 2009 Sep;250(3):484-93. 142. Alonso EM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Varni JW; Studies of Pediatric Liver Transplantation (SPLIT), Functional Outcomes Group (FOG).* Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr. 2010 Feb;156(2):270-6.e1. Epub 2009 Oct 28.
143. Venick RS, Farmer DG, McDiarmid SV, Duffy JP, Gordon SA, Yersiz H, Hong JC,
Vargas JH, Ament ME, Busuttil RW. Predictors of survival following liver transplantation in infants: a sinlge-center analysis of more than 200 cases. Transplantation. 2010 Mar 15;89(5):600-5.
144. Pescovitz MD, Ettenger RB, Strife CF, Sherbotie JR, Thomas SE, McDiarmid S,
Bartosh S, Ives J, Bouw MR, Bucuvalas J. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients. Transpl Infect Dis. 2010 Jun;12(3):195-203. Epub 2009 Dec4.
145. AlonsoEM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Varni JW;
Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG).* Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr. 2010 Feb;156(2):270-6.e1. Epub 2009 Oct 28.
146. Weissberg-Benchell J, Zielinski TE, Rodgers S, Greenly RN, Askenazi D, Goldstein SL,
Fredricks EM, McDiarmid S, Williams L, Limbers CA, Tuzinkiewicz K, Lerret S,
Alonso EM, Varni JW. Pediatric health-related quality of life: Feasibility, reliability and
validity of the PedsQL transplant module. AM J Transplant. 2010 Jul;10(7):1677-85

147. Zarkhin V, Talisetti A, Li L, Wozniak LJ, McDiarmid SV, Cox K, Esquivel C, Sarwal
MM. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation. 2010 Nov 15;90(9):1000-5.
148. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, Venick RS, Feist S,
Goldstein L, Saab S, Hiatt JR, Busuttil RW. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010 Oct;252(4):652-61.
149. Farmer DG, Venick RS, Colangelo J, Esmailian Y, Yersiz H, Duffy JP, Cortina GR,
Artavia K, Ngo K, McDiarmid SV, Busuttil RW. Pretransplant predictors of survival
after intestinal transplantation: analysis of a single-center experience of more than 100
transplants. Transplantation. 2010 Dec 27;90(12):1574-80.

150. Varni JW, Limbers CA, Sorensen LG, Neighbors K, Martz K, Bucuvalas JC, Alonso EM;
Studies of Pediatric Liver Transplantation Functional Outcomes Group.* Reliability and validity. Qual Life Res. 2011 Aug;20(6):913-21. Epub 2010 Dec 24.
151. Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Varni JW, Alonso EM;
Studies of Pediatric Liver Transplantation Functional Outcomes Group.* Health-related quality of life in pediatric liver transplant recipients compared with other chronic disease groups. Pediatr Transplant. 2011 May;15(3):245-53. doi: 10.111/j.1399-3046.2010.01453.x. Epub 2010 Dec 29.
152. Martin SR, Alvarez F, Anand R, Song C, Yin W; SPLIT Research Group*. Outcomes in
children who underwent transplantation for autoimmune hepatitis. Liver Transpl. 2011 Apr;17(4):393-401. 153. McDiarmid SV, Anand R, Martz K, Millis MJ, Mazariegos G. A multivariate analysis of
pre-, peri-, and post- transplant factors affecting outcome after pediatric liver transplantation. Ann Surg. 2011 Jul;254(1):145-54.
154. Venick RS, Wozniak LJ, Colangelo J, Beckwith P, Reyen L, Esmailian YA, McDiarmid
SV, Vargas JH, Ament ME, Busuttil RW, Farmer DG. Long-term nutrition and predictors
of growth and weight gain following pediatric intestinal transplantation. Transplantation.
2011 Nov 15;92(9):1058-62.

155. Ngo KD, Farmer DG, McDiarmid SV, Artavia K, Ament ME, Vargas J, Busuttil RW,
Colangelo J, Esmailian Y, Gordon-Burroughs S, Duffy J, Venick RS. Pediatric health-related quality of life after intestinal transplantation. Pediatr Transplant. 2011 Dec;15(8):849-54.
156. Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, Mazariegos G,
Magee J, McDiarmid SV, Anand R; Studies of Pediatric Liver Transplantation (SPLIT)
Research Group. Health Status of Children Alive 10 Years after Pediatric Liver
Transplantation Performed in the US and Canada: Report of the Studies of Pediatric
Liver Transplantation Experience. J Pediatr. 2011 Dec 20.
157. McDiarmid SV; 21 years old-who cares?. Am J Transplant.2012 Jun;12(6):1367-9.
158. Li L, Wozniak LJ, Rodder S, Heish S, Talisetti A, Wang Q, Esquivel C, Cox K, Chen R. McDiarmid SV, Sarwal MM. A Common Peripheral Blood Gene-Set for Diagnosis of
Operational Tolerance in Pediatric and Adult Liver Transplantation. American Journal of
Transplantation. 2012 May;12(5):1218-28
159. Pongpaibul A, Venick R, McDiarmid S, Lassman C. Histopathology of De Novo
Autoimmune Hepatitis. Liver Transplantation. 2012 July;18(7):811-8 160. Farmer DG, Kattan OM, Wozniak LJ, Marcus E, Ponthieux S, Hwang V, Busuttil RW, McDiarmid SV, Venick RS. Incidence, timing, and significance of early
hypogammaglobulinemia after intestinal transplant. Transplantation.2013 may
15;95(9);1154-9.
161. Petrowsky H, Brunicardi FC, Leow VM, Venick RS, Agopian V, Kaldas FM, Zarrinpar A, Markovic D, McDiarmid SV, Hong JC, Farmer DG, Hiatt JR, Busuttil RW. Liver
transplantation for lethal genetic syndromes: a novel model of personalized genomic
medicine. J Am Coll SUrg.2013 Apr;216(4):534-43.
162. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Hartlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI,
Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW. The evolution of liver
transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single
center. Ann Surg.2013 Sep;258(3):409-21
163. McDiarmid SV. Adolescence: challenges and responses. Liver Transpl.2013 Nov;19
164. McDiarmid SV. Donor and procurement related issuesin vascularized composite
allograft transplantation. Curr Opin Organ Transplant. 2013 Dec;18(6):665-71. 165. Hong JC, Venick R, Yersiz H, Kositamongkol P, Kaldas FM, Petrowsky H, Farmer DG, Agopian V, McDiarmid SV, Hiatt JR, Busuttil RW. Liver transplantation in children
using organ donationafter circulatory death: a case-control outcomes analysis of a 20-
year experience in a single center. JAMA Surg. 2014 Jan;149(1):77-82.
166. O'Leary JG, Demetris AJ, Friedman, LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ,
Woodles ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloatibodies
in liver transplantation. Am J Transplant. 2014 Apr;14(4):779-87.
167. Yeh J, Ngo KD, Wozniak LJ, Vargas JH, Marcus EA, McDiarmid SV, Farmer DG,
Venick RS. Endoscopy Following Pediatric Intestinal Transplant: A 23 Year Single Center Experience. J Pediatr Gastroenterol Nutr. 2015 May 25. [Epub ahead of print] 168. Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid
SV, Reed EF. Donor-specific HLA Antibodies Are Associated With Late Allograft
Dysfunction After Pediatric Liver Transplantation. Transplantation. 2015 Jul;99(7):1416-
22.
169. Kim JY, Balamurugan A, Azari K, Hofmann C, Ng HL, Reed EF, McDiarmid S, Yang
OO. Clonal CD8+ T Cell Persistence and Variable Gene Usage Bias in a Human Transplanted Hand. PLoS One. 2015 Aug 19;10(8):e0136235. * Cited collaborator in Studies of Pediatric Liver Transplantation (SPLIT) multicenter study
Invited Reviews:

1.
McDiarmid SV, Ettenger RB, Fine RN, Busuttil RW, Ament ME. Glomerular filtration
rate decreases serially in long term pediatric liver transplantation survivors treated with
cyclosporin A. IN: Year Book of Surgery. Swartz (ed). Mosby Year BooK, Inc. St. Louis,
MO 1990, pp 116-117.
McDiarmid SV, Millis MJ, Terasaki P, Vargas JH, Ament ME, Busuttil RW. Induction
of immunosuppression in pediatric orthotopic liver transplantation. Clin Transplantation.
1991;5:174-180.
McDiarmid SV, Millis MJ, Terasaki P, Ament ME, Busuttil RW. OKT3 prophylaxis in
liver transplantation. Digestive Diseases and Science. 1991;36:1427-1430.
McDiarmid SV. Renal function in pediatric liver transplant patients. Kidney
International
. 1996;77-84.
McDiarmid SV. Mycophenolate mofetil in liver transplantation. Clinical
Transplantation
10 (1 Pt 2): 140-145, 1996.
McDiarmid SV. Uses of Neoral in pediatric liver transplantation. Transplantation
Proceedings
28 (4):2264-2266, 1996.
McDiarmid SV. Risk factors and outcomes after pediatric liver transplantation. Liver
Transplantation and Surgery. 2(5):44-56. 1996.
Lucey MR; Brown KA; Everson GT; Fung JJ; Gish R; Keeffe EB; Kneteman NM; Lake
JR; Martin P;McDiarmid SV; Rakela J; Shiffman ML; So SK; Weisner RH. Minimal
criteria for placement of adults on the liver transplant waiting list: a report of a national
conference organized by the American Association for the Study of Liver Diseases. Liver
Transplantation and Surgery
. 1997;3(6): 628-37.
McDiarmid SV. The use of tacrolimus in pediatric liver transplantation. Journal of
Pediatric Gastroenterology and Nutrition
. 1998;26:90-102.
McDiarmid SV, Millis MJ, Olthoff KM, So SK. Indications for pediatric liver
transplantation. Pediatric Transplantation. 1998;2:106-116.
McDiarmid SV. The necessity for steroid induction or long-term maintenance after liver
transplantation: the argument against. Transplantation Proceedings.1998;30:1449-51.
McDiarmid SV. The liver and metabolic disease of childhood. Liver Transplantation
and
Surgery. 1998;4(5 Suppl 1):S34-50.
Hold CD, Sievers TM, Rafik MG, Rossi SJ, Goss JA, McDiarmid SV. Mycophenolate
mofetil: Effect on clinical transplantation. Biodrugs 1998;(10):373-384.
McDiarmid SV. Late liver graft dysfunction. Graft 1999.
McDiarmid SV. Mycophenolate mofetil as induction therapy after liver transplantation.
Liver Transplantation and Surgery. 1999;(4 Suppl 1):S85-9.
McDiarmid SV. Liver Transplantation. The Pediatric Challenge. Clin Liver Disease
2000;(4):879-927 Review.
McDiarmid SV. How can we optimize the outcome of liver grafts from pediatric donors?
Liver Transplantation 2001;(1):48-50.
Kaufmann SS;Atkinson JB; Bianchi A; Goulet OJ; Grant D; Langas AN; McDiarmid
SV
; Mittal N ; Reyes J ; Tzakis AG. Indications for pediatric intestinal transplantation: a
position paper of the American Society of Transplantation. Pediatric Transplantation
2001;(2):80-7 Review.
McDiarmid SV. Management of the pediatric liver transplant patient. Liver
Transplantation
2001;(11 Suppl 1):S77-86 Review.
McDiarmid SV. New liver allocation policies and their potential effect on pediatric
patients awaiting liver transplantation. Pediatric Transplantation 2002;3:180-6.
Sokal EM; Cleghorn G; Goulet O; Da Silveira TR; McDiarmid SV; Whitington P. Liver
and intestinal transplantation in children:Working Group Report of the First World
Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatric
Gastroenterology Nutrition
2002; (35 Suppl 2):S159-72.
Bostom AD; Brown RS Jr; Chavers BM; Coffman TM; Cosio FG; Culver K; Curtis JJ;
Danovitch GM; Everson GT; First MR; Garvey C; Grimm R; Hertz MI; Hricik DE;
Hunsicker LG; Ibrahim H; Kasiske BL; Kennedy M; Klag M;Knatterud ME;
Kobashigawa J; Lake JR; Light JA; Matas AJ; McDiarmid SV; Miller LW; Payne WD;
Rosenson R; Sutherland DE; Tejani A; Textor S; Valentine HA; Wiesner RH. Prevention
of post-transplant cardiovascular disease—report and Recommendations of an ad hoc
group. Am J Transplant 2002;2(6):491-500.
Freeman RB Jr; Wiesner RH; Harper A; McDiarmid SV; Lake J; Edwards E; Merion R;
Wolfe R; Turcotte J; Teperman L. The new liver allocation system: moving toward
evidence-based transplantation policy. Liver Transplantation 2002;9:851-8.
McDiarmid SV. Liver transplantation for chronic hepatitis B and C: dilemmas and
controversies. Liver Transplantation 2002;(10 Suppl 1):S1-2.
McDiarmid SV; Bucuvalas JC; Cox KL; Freese DK; Rosenthal P; Vanderhoof JA.
Research agenda for pediatric gastroenterology, hepatology and nutrition:transplantation.
Report of the North American Society for Pediatric Gastroenterology, Hepatology and
Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatric
Gastroenterology Nutrition
2002; (35 Suppl 3): S275-80.
Colobani PM, Dunn SP, Harmon WE, Magee JC, McDiarmid SV, Spray TL. Pediatric
transplantation. Am Journal Transplantation. 2003;3 (Suppl 4):53-63.
McDiarmid SV. Current status of liver transplantation in children. Pediatric Clin North
America
. 2003;50(60):1335-74.
Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM,
Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR. Summary report of a national
Conference:Evolving concepts in liver allocation in the MELD and PELD era. Liver Transplant. 2004;10 (Suppl 2):A6-22. McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates
under the PELD system. Liver Transplantation. 2004;10(10 Suppl 2):A6-22.

Editorials

1. McDiarmid SV. Renal function in pediatric liver transplant recipients. Transplantation
2. McDiarmid SV. United Network for Organ Sharing rules and organ availability for
children: current policies and future directions. Pediatric Transplantation 2001;4:561-2 3. McDiarmid SV. The new liver allocation system: how will children be affected?J Pediatric
Gastroenterolgy Nutrition 2002;3:243-5.
Chapters

1. Hyman PE, Tomomasa T, McDiarmid SV. Chronic intestinal pseudo-obstruction in
children. In: Miller PJ and Weburn P, eds. Pediatric Gastrointestinal Motility Disorders and the Role of Cisapride. Sussex: John Wiley & Sons. 1988.
2. Imagawa DK, Strange SM, Shaked A, Seu P, Colonna JO, Farmer D, McDiarmid SV,
Morrissey MP, Busuttil RW. Liver transplantation at UCLA: Report of clinical activities. In: P. Terasaki, Ed. UCLA Tissue Typing Laboratory, Los Angeles, California. Clinical Transplants. 1991. 3. McDiarmid SV. Liver transplantation for metabolic disease. In: Busuttil RW, Klintmalm
G. (eds.) Transplantation of the Liver. W.B. Saunders Co., New York. 1993. 4. McDiarmid SV. Special considerations for pediatric immunosuppression after liver
transplantation. In: Busuttil RW, Klintmalm G. (eds.) Transplantation of the Liver.W.B. Saunders Co., New York. 1993. 5. McDiarmid SV. Renal dysfunction in pediatric liver transplant patients. In: Busuttil RW,
Klintmalm G. (eds.) Transplantation of the Liver. W.B. Saunders Co., New York. 1993. 6. Menkes JH, Hurvitz CGH, McDiarmid SV, Williams R. Neurologic manifestations of
systemic disease. Menkes JH (ed). Textbook of Child Neurology. 5th edition;14:873-923. 7. McDiarmid SV. Liver transplantation in children. Transplantation. Ginns, Cosimi, and
Morris. (editors). Blackwell Science. Maryland. 2000 8. McDiarmid SV, Kay M. Liver failure in transplantation. Pediatric Gastrointestinal
Disease (2nd edition) Wyllier, Hyams JS. (editors). WB Saunders Company, Florida. 2000 9. McDiarmid SV. Treatment of end-stage liver disease. Pediatric Gastrointestinal Disease
(3rd Edition) walker, Durie, Hamilton, Walker-Smith, Watkins (editors) B.C. Decker Inc. Ontario 2000 10. Ghobrial RM, Amersi F, McDiarmid SV, Busuttil RW. Pediatric Liver Transplantation.
In: Maddrey, Sorrell and Schiff (ed.) . Transplantation of the Liver.Lippincott, Williams and Wilkins, Chapter 7 11. McDiarmid SV, Anand R, SPLIT Research Group. Studies of Pediatric Liver T
ransplantation (SPLIT): a summary of the 2003 Annual Report. Clin Transplantation 2003;:119-30. 12. McDiarmid SV. Liver transplantation for metabolic disease. In: Busuttil RW, Klintmalm
G. (eds.) Transplantation of the Liver. (Second Edition)W.B. Saunders Co., New York. 2005 13. McDiarmid SV. Special considerations for pediatric immunosuppression after liver
transplantation. In: Busuttil RW, Klintmalm G. (eds.) Transplantation of the Liver. (Second Edition) W.B. Saunders Co., New York. 2005. 14. McDiarmid SV. Treatment of end-stage liver disease. Pediatric Gastroenterology Disease
(4th Edition). Kleinman, Goulet,Mieli-Vergani,Sanderson, Sherman, Schneider (editors) BC Decker Inc. Ontario 2008 15. McDiarmid SV, Azari KK. Donor-related issues in hand transplantation. Hand Clin. 2011
Nov;27(4):545-52, x-xi. 16. Venick RS and McDiarmid SV "Transplantation for Metabolic Disease" Transplantation
of the Liver. Ed. R Busuttil and G Klintmalm- Third Edition 2015. 1. Esquivel CO, So SK, McDiarmid SV, Andrews WS, Colombani PM. Suggested guidelines
for the use of tacrolimus in pediatric liver transplant patients {letter}. Transplantation 61 (5):847-848, 1996. 2. Tilney N, Murray J, Thistlethwaite R, Norman D, Delmonico F, Hanto D, Leichtman A, Danovitch G, Sayegh M, Shapiro R, Harmon W, Salvatierra O, Brennan D, McDiarmid S,
Stock P, Pomfret L, Bennett W, Conti D, Metzger B, Sarwal M, Cosimi AB. Promotion of
altruistic donation. Transplantation. 2009 Sep 27;88(6):847. No abstract available. Erratum
in: Transplantation. 2009 Nov 15;88(9):1145-7
Published Abstracts Peer-Reviewed

1. McDiarmid S, Vargas JH, Ament ME. Intestinal motility in Cockayne's syndrome. Clinical
Research. 1987:35(1).
2. McDiarmid SV, Ament ME, Vargas JH, Henar E, Self T, Tipton J, Busuttil RW. Interferon
Therapy for de novo Hepatitis C after pediatric orthotopic liver transplantation. Pediatric Nephrology.1996;10:C31-C94;PO989.
3. McDiarmid SV, Busuttil RW. Primary immunosuppressive therapy with tacrolimus.
Pediatric Nephrology.1996;10:C31-C94;S16.
4. McDiarmid SV, Busuttil RW, Goss J, Vargas J, Ament ME. Causes of late graft
dysfunction after pediatric liver transplantation. Liver Transplantation and Surgery. 1997;3(5):C-47.
5. McDiarmid S, Anand R. EBV disease and lymphoproliferative disease (LPD) after a first
liver transplant in children enrolled in the SPLIT registry. Liver Transplantation.2000;6:C33
6. McDiarmid SV, Davies DB M.S., Edwards EB Ph.D. Odds of patient death at low volume
pediatric liver transplants compared to high volume programs. Transplantation. 1999;67(7):913
7. McDiarmid SV, Davies DB M.S., Edwards EB Ph.D. Pediatric liver recipients have a better
graft survival if transplanted with pediatric-aged liver donors. Transplantation. 1999;67(7):1055
8. McDiarmid SV, Anand R. Outcome of cyclosporine and tacrolimus treated pediatric
patients enrolled in the SPLIT registry. Transplantation. 2000;69(8):5338
9. McDiarmid SV, Anand R, EBV Disease and Lymphoproliferative Disease (LPD) after a
first liver transplant in children enrolled in the SPLIT registry. In studies of Pediatric Liver Transplantation. Liver Transplantation May 2000;6:C-33.
10. McDiarmid S, Anand R, SPLIT Research Group. Immunosuppression, rejection and effect
on outcome in children after liver transplantation. Liver Transplantation 2003 9;(6) C-47.
11. McDiarmid S, Harper A, Events on the liver waiting list since PELD and MELD:
comparing children and adults. American Journal of Tranplantation 2003;3 (Suppl 5) 179.
12. McDiarmid S, Anand R, SPLIT Research Group. A multivariate analysis of factors
effecting patient and graft survival after pediatric liver transplantation. American Journal of Transplantation 2003;3 (Suppl 5) 387. 13. McDiarmid S, Anand R, SPLIT Research Group. Outcome of ABO incompatible liver
grafts in children. American Journal of Transplantation 2004; Vol 4 (Suppl 8) 419.
14. McDiarmid S, Harper A, Are too many pediatric liver recipients transplanted at Status 1.
American Journal of Transplantation 2004; Vol 4 (Suppl 8) 436.
15. McDiarmid S, Anand R, and the SPLIT Research Group. Death on the waiting list for
children with fulminant liver failure registered in the Studies of Pediatric Liver Transplant (SPLIT) database. Liver Trnasplantation 2005;11: C21
16. McDiarmid SV, Goodrich NP, Dykstra DM, Reyes JD, Merion RM. Status 1 candidate
mortality on the liver transplant waitlist. American J of Transplantation 2005;5 (suppl 11): 264
17. McDiarmid SV, Anand R, and the SPILT Research Group. Multivariate analysiss of
predictors of waiting list mortality for children with acute liver failure: implications for donor allocation. American J of Transplantation 2006; PP 1-1145;273
18. McDiarmid SV, Anand R, Changhong S. and the SPLIT Research Group. Post transplant
events are the strongest predictors of patient and graft survival 6 months after pediatric liver transplantation. American J of Transplantation 2007;7(suppl 2): 242
19. McDiarmid S, Anand R, Song C, SPLIT Research Group. Inferior survival after
liver+kidney transplantation for children with primary hyperoxaluria. Liver Transplantation 2008; 14(7) Suppl 1:213
20. Venick R, McDiarmid S, Farmer D, Feist S, Duffy J, Hong J, Vargas J, Ament M, Busuttil
R. Pediatric Liver Transplant Recipient 20 Years later: Guarded Optomism. Liver Transplantation. 2009;15:S118
21. Venick R, Ngo K, McDiarmid S, Colangelo J, Esmalian Y, Gordon S, Duffy J, Ament M,
Busuttil R. Liver Transplantation 2009;15:S106
22. Venick R, McDiarmid S, Farmer D, Feist S, Duffy J, Vargas J, Ament M, Busuttil R. The
Impact of H1N1 Influenza on Pediatric Liver Transplantation. Liver Transplantation 2010;6:S115
23. Venick R, McDiarmid S, Farmer D, Feist S, Duffy J, Vargas J, Ament M, Busuttil R. The
Efficiency of CMV Immune Globulin in Preventing EBV Viremia and PTLD in Pediatric Liver and Intestinal Transplant. Liver Transplantation 2010;6:S116

Invited Lectures and Abstract Presentations

"Nutrition in very low birth weight infants" to the Virginia Chapter of the American Academy of Pediatrics. Williamsburg. February 1981. "Antroduodenal motility studies in children" Mead-Johnson Conference, Scottsdale, Arizona. February 1987. American Society of Transplantation Physicians. Chicago. (1) Glomerular filtration rate decreases serially in long term pediatric liver transplantation survivors treated with cyclosporin A. The decline of cytotoxic antibody levels after orthotopic liver transplantation. May 1988. (Poster) XII International Congress of the Transplantation Society. "The development of a lymphocyte population with a suppressor phenotype after successful liver transplantation. Sydney, Australia. August 1988. Canadian Liver Transplant Workshop. "Immunosuppression." Toronto, Canada. October 1988. International Association for the Study of Liver. "OKT3 prophylaxis in liver transplantation. " Toronto, Canada. October 1988. British Columbia Children's Hospital. "Liver transplantation - an overview." Vancouver, British Columbia. October 1988. American Society of Transplantation Physicians "The fall in true GFR in pediatric allograft recipients treated with Cyclosporine." Chicago. May 1989. North American Society of Pediatric Gastroenterology and Nutrition. True GFR in pediatric liver transplant recipients treated long term with Cyclosporine. Chicago. Oct. 1989 European Society for Organ Transplantation. Low OKT3 serum levels correlate with failure of OKT3 prophylaxis in live transplant patients. Barcelona, Spain. Nov. 1989. University of Cordoba, Spain. "The present and future of monoclonal antibody therapy in transplantation." Nov. 1989. University of Cordoba, Spain. "Practicalities of Cyclosporine use." Nov. 1989. Liver Transplantation Round Table (Sandoz) Long term survivors after liver transplantation - complications and management. Phoenix. Feb. 1990. Joint Meeting of the European and North American Societies of Pediatric Gastroenterology and Nutrition. "OKT3 treatment of steroid resistant rejection in pediatric liver transplant recipients. Chicago, May 1990. International Congress of the Transplantation Society. Longterm results of a randomized prospective study of OLT prophylaxis in liver transplant recipients. San Francisco, August 1990. Liver Transplantation - A Revolution in Pediatric Hepatology. John Adams Day, U.C.L.A. Medical Center, June 1990. Practical and Ethical Issues in Pediatric Organ Transplantation. Regional Organ Procurement Agency of Southern California. November 1990. New Immunosuppressives in Liver Transplantation. British Columbia Transplant Society Grand Rounds. May 1991. Advances in Pediatric Liver Transplantation. British Columbia's Childrens Hospital. Grand Rounds. May 1991. American Society of Transplant Physicians. Serum lipid abnormalities in pediatric liver transplant recipients. Chicago, May 1992. American Society of Transplant Physicians. Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. Chicago, May 1992. International Congress of the Transplantation Society.ä A Comparison of renal function in cyclosporine and FK506 treated patients after primary orthotopic liver transplantation. Paris, France, August 1992. American Society of Transplant Physicians. A multicenter prospective randomized trial comparing FK506 to cyclosporine after liver transplantation. Comparison of efficacy based on incidence, severity and treatment of rejection. Houston, May 1993. New Immunosuppressives in pediatric liver transplantation. Invited lecture. University of California at San Francisco. San Francisco, 1993 First International Congress on Pediatric Transplantation. FK506 successfully reverses intractable rejection after orthotopic liver transplantation in children. Minneapolis, September 1993. European Society of Organ Transplantation. Oral FK506 after liver transplantation: Successful early conversion from intravenous use; efficacy and advantage of initial oral therapy. Rodos, Greece, October 1993. International Symposium on Small Bowel Transplantation. Intragraft cytokine
and CTL specific protein expression are predictors of rat small intestine transplant
rejection. Paris, France, November 1993.
Farmer DG, McDiarmid SV, Kuniyoshi J, Robert M. Shaked A, Busuttil RW.
Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis
factor-alpha are predictors of rat small intestine transplant rejection. Association
for Academic Surgery. 1993.
Update in Pediatric Liver Transplantation. Grand Rounds. Sunrise Children's Hospital, Las Vegas, NV. April 1994. Pediatric Liver Transplantation. Grand Rounds. Kaiser Permanente, Los Angeles, CA, April 1994. Update in Pediatric Liver Transplantation. Grand Rounds. UCLA Medical Center, Los Angeles, CA. April 1994. FK506 compared to cyclosporine for primary immunosuppression after pediatric liver transplantation: Results from the U.S. multicenter trial. Chicago, May 1994. Use of FK506 in children. South Western University, Dallas, TX. Aspen conference on pediatric liver disease and transplantation. Invited Faculty. Colorado. July 1994. Liver Transplantation. North American Society of Pediatric Gastroenterology and Nutrition. Post Graduate Course. Houston, TX. The use of FK506 in Pediatric Liver Transplantation. Children's Hospital Medical Center. Cincinnati University Hospital. Cincinnati, OH. Pediatric Liver Transplantation. Mayo Clinic Grand Rounds. Rochester, MN. December 1994. Advances in Pediatric Liver Transplantation. Grand Rounds. Children's Hospital of the King's Daughters. Norfolk, VA. March 1995. Pediatric Liver Transplantation: Renal Complications. North American Pediatric Renal Transplant Cooperative Study. San Francisco, CA. March 1995. FK506 in Pediatric Liver Transplantation. Controversies in Transplantation. Breckinridge, CO. April 1995. Graft Survival After Pediatric Liver Transplantation. American Society of Transplant Physicians. Chicago, IL. May 1995. Results of a Randomized Prospective Trial of Steroid Withdrawal after Liver Transplantation. American Society of Transplant Physicians. Chicago, IL. May 1995. Grand Rounds. Pediatric Liver Transplantation. Harbor - U.C.L.A. June 1995. A randomized prospective trial of steroid withdrawal after liver transplantation. (Abstract). American Society of Transplant Physicians. Chicago, IL. May 1995. Mycophenolate Mofetil in Liver Transplantation International Congress on New Immunosuppressive Drugs. Minneapolis, MI, August 1995. Challenges in Immunosuppression Round Table: Current Practice in Pediatric Liver Transplantation Advances in Immunosuppression: Mycophenolate Mofetil Joint Congress on Liver Transplantation London, England. September 1995. The Liver Transplant Evaluation: Linking Risk Factors and Outcome: Special Considerations in Pediatric Candidates ASSLD/ILTS Transplant Course. Chicago, IL. November 1995. Uses of Neoral in Pediatric Liver Transplant Patients Cybercongress. Washington, D.C. November 1995. Grand Rounds: Pediatric Liver Transplantation Cardinal Glennon Children's Hospital. St. Louis, MO. April 1996. Grand Rounds: Update in Pediatric Liver Transplantation. Cedars Sinai Medical Center. Los Angeles, CA. April 1996. Outcome of Tacrolimus converted Liver Transplant Recipients comparing hepatitis C positive with hepatitis C negative patients. (Abstract). American Society of Transplant Physician Annual Meeting. Chicago, IL. May 1996. Factors Affecting Growth after Pediatric Liver Transplantation. The 16th Sigrid Juselius International Symposium. Espoo, Finland. June 1996. Acute Hepatic Failure. Queen of Angels-Hollywood Presbyterian Medical Center. June 1996. Immunosuppressive Drugs Specific for Liver Transplantation Pediatric Patients Special Consideration Fellows Symposium on Transplantation Medicine. St. Louis, MI. July 1996 . Grand Rounds: Update in Pediatric Liver Transplantation Ochsner Foundation Hospital, New Orleans, LO. August 1996. Grand Rounds: Update in Pediatric Liver Transplantation Louisiana State University Hospital. Shreveport, LA. August 1996. Primary Immunosuppressive Therapy with tacrolimus after Pediatric Liver Transplantation. The 2nd International Congress on Pediatric Transplantation. Paris, France. August 1996. Liver Disease in Childhood. Pediatric Board Review Course. U.C.L.A. September 1996. Grand Rounds: Immunosuppression in Pediatric Liver Transplant Patients. University of Wisconsin-Madison Medical School. September 1996. Grand Rounds: Pediatric Liver Transplantation. University of Alabama at Birmingham. November 1996. Grand Rounds: Pediatric Liver Transplantation. New approaches to the Organ Shortage. Loma Linda University Hospital. December 1996. "Indications for listing for pediatric liver transplantation". NIH Consensus Conference. Washington D.C. February 1997. "Long-term results of pediatric liver and kidney transplantation". University of Colorado Breckinridge Conference. April 1997. "Pediatric post-transplant lymphoproliferative after pediatric liver transplantation". Post-transplant Lymphoproliferative Disease Conference. Chicago, Illinois. May 1997. "The safety of neoral conversion in pediatric liver transplant recipients". Abstract Presentation. American Society of Transplant Physicians. Chicago, Illinois. May 1997. "Growth after pediatric liver transplantation". International Symposium on Growth after Pediatric Liver Transplantation. Brussels, Belgium. May 1997. "Fulminant hepatic failure",and "Advances in pediatric liver transplantation". Grand Rounds. Bishop, California. July 1997. "Special Considerations in Pediatrics." Fellows Symposium on Transplantation Medicine. St. Louis, Missouri. July 1997 "Causes of late graft dysfunction after pediatric liver transplantation ". Abstract Presentation. International Transplant Society. Seattle, Washington. October 1997. "Advances in surgical management and immunosuppression in pediatric liver transplantation" and "Growth after pediatric liver transplantation". Grand Rounds (2). University of Pennsylvania. Philadelphia, Pennsylvania. October 1997. "Metabolic liver disease of the liver". Post-graduate course. American Association for the Study of Liver Disease. Chicago, Illinois. November 1997. "Steroid withdrawal after liver transplantation - Invited debate", "100 Pediatric liver transplant patients treated with tacrolimus". The International Congress on Immunosuppression. Florida. December 1997. "One hundred children treated with tacrolimus after primary orthotopic liver transplantation". The International Congress on Immunosuppression. Abstract presentation. Miami, Florida. December 1997. "Split and Living Related Transplantation" Controversies in Transplantation. Breckenridge CO. March 14 1998. "Safety Profile of Prograf in Pediatric Transplantation" International Symposium on Pediatric Transplantation. Madrid, Spain. March 27 1998. "Hepatitis in Pediatric Patients": Grand Rounds Kaiser Permanente. Los Angeles, CA April 2 1998. "Steriod withdrawal after Pediatric Transplantation". Update in Pediatric Liver Transplantation. New York, NY April 9 1998. "Jaundice in Childhood". Grand Rounds. Sunrise Hospital, Las Vegas, NV April 16 1998. "Prevention and Preemptive Therapy of Post-Transplant Lymphoproliferative Disease". American Society of Transplant Phyicians Annual Meeting. Chicago, IL. May 11 1998. "Risk factors for Pediatric Liver Transplantation". American Society of Transplant Physicians Annual Meeting. Chicago, IL. May 12 1998. "Split Liver Transplantation". ASTP/ASTS Pediatric Symposium. Chicago, IL. May 13 1998. "Factors Affecting Growth after Pediatric Liver Transplantation". XVII World Congress of the Transplantation Society. Montreal, Canada July 16 1998. "Report from the studies of Pediatric Liver Transplantation". XVII World Congress of the Transplantation Society. Montreal, Canada. July 16 1998. "Steriod Withdrawal after Liver transplantation". Grand Rounds. St Louis, MO. Sept 16 1998. "Mycophenolate as Induction Therapy after Liver Transplantation". American Association for the study of Liver Disease, Transplant Course. Chicago, IL. Nov 8 1998. "Immunosuppression after Pediatric Liver Transplantation". American Association for the study of Liver Disease. Chicago, IL. Nov 8 1998. "Recognizing Liver Disease in Children". Management of Pediatric Liver Disease Symposium. Columbia Presbyterian Hospital New York, NY. Dec 5 1998 . "Primary Care of the Pediatric Post Liver Transplant Patient". Management of Pediatric Liver Disease Symposium, Columbia Presbyterian Hospital. New York, NY. Dec 5 1998. "Causes of Late Liver Graft Dysfunction". American Society of Transplant
Physicians,Winter Symposium. Hawaii. January 16 1999.
"Hepatobiliary Diseases in Children". UCLA Hepatobiliary Symposium. Los Angeles, CA Feb 20 1999. "Hepatitis C in Children." Grand Rounds Children's Hospital of Orange County. Los Angeles, CA March 17 1999. "Tacrolimus Immunosuppression in Pediatric Liver Transplantation." Grand Rounds Hospital for sick children, Toronto, Ontario. June 3rd 1999. "Current Issues in Liver Transplantation." Grand Rounds University of Massachusetts Medical School. October 22nd 1999. "Special Considerations for Pediatric Transplant patients"American Society of Transplantation Winter Symposium Puerto Rico. January 13-16, 2000 "The Challenges of Pediatric Transplantation"Grand Rounds. University of Alberta, Edmonton, Canada February 2, 2000 "Diagnosis and Treatment of Post-Transplant Lymphoproliferative Disease" Controversies in Transplantation. University of Colorado School of Medicine. Breckenridge March 17-19, 2000 "Long-Term Prognosis after Pediatric Liver Transplantation"Alex Mowat Memorial Symposium Kings College, London, England April 5, 2000 "Outcome of Cyclosporine and Tacrolimus Treated Pediatric Liver Patients; SPLIT Data" American Society of Transplantation Annual Meeting Chicago May 13-17, 2000 "Issues in Adolescent Transplantation" American Society of Transplantation, Annual Meeting Chicago May 13-17, 2000 "EBV and Lymphoproliferative Disease after a First Liver Transplant in Children enrolled in the SPLIT Registry" (Abstract) International Liver Transplant Society Annual Meeting Buenos Aires, Argentina June 21-23, 2000 "Post Transplant Lymphoproliferative Disease-Overview" International Liver Transplant Society Buenos Aires, Argentina June 21-23, 2000 "Tacrolimus-Present and Future. Japanese LiverTransplantation Society Kyoto, Japan July 16, 2000 "Is Withdrawal of Immunosuppression Ever Possible After Pediatric Liver Transplantation? Pro" International Pediatric Transplant Association Meeting Venice, Italy August 23-25, 2000 "Advances in Pediatric Liver and Intestinal Transplantation" International Society of Transplantation Rome, Italy August 30, 2000 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September 11, 2000 "New Immunosuppressive Agents-Meet the Professor Workshop"Dallas October "Cardiovascular Risk Factors in Pediatric Liver Transplantation" Symposium for Long Term Risk Factors After Solid Organ Transplantation Phoenix. November 2, 2000 "Studies of Pediatric Liver Transplantation Registry-Update" National Institutes of Health Round Table Bethesda, MA. Dec 12, 2000 "Bile Hepatitis in Children" "Approched Metabolic Liver Disease" "Cholestasis in Children" "Complications after Liver Transplantation" An International Update on Hepatobiliary Disease. Bangalore, India. January 13-17, 2001 "Complications After Liver Transplantation" Noon Conference Pediatric Residents, UCLA. April 11, 2001 "Bile Hepatitis in Children" "Cholestatic Disease" Seminars in Pediatric Gastroenterology. Peoria, IL. April 21, 2001 "Recurrent Disease After Pediatric Liver Transplantation" American Society of Transplantation Annual Meeting. Chicago, IL. May 11-16, 2001 "Development of a Pediatric End-Stage Liver Disease Severity Score" (Abstract) American Society of Transplantation Annual Meeting. Chicago, IL. May 11-16, 2001 "Transplantation in Infants" Meet the Professor Workshop. American Society of Transplantation Annual Meeting. Chicago, IL. May 11-16, 2001 "Post-Transplant Lymphoproliferative Disease after Pediatric Liver Transplantation" Grand Rounds. Children's Hospital of British Columbia, Vancouver. May 30, 2001 "Pro and Con: ABO Incompatibility in Pediatric Liver Transplantation" International Liver Transplant Society Annual Meeting. Berlin, Germany. July 10-13, 2001 "Pediatric Transplantation-Liver"A Transplant Odyssey. Istanbul, Turkey. August 20-23, 2001 "Lessons Learned: Pediatric Liver Transplantation at UCLA"Grand Rounds Mattel Children's Hospital, UCLA. September 7, 2001 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September 11, 2001 "Prevention and Treatment of Post Transplant Lymphoproliferative Disease After Pediatric Liver Transplantation". Grand Rounds, Medical College of Virginia. Richmond, VA. October 25, 2001 "Management of Pediatric Liver Transplantation Patients" American Association for the Studies of Liver Disease. Dallas. November 9, 2001 "How Well Can a Grafted Liver Improve a Recipients Metabolic and Nutritional Condition?" 17th Annual Symposium of Japanese Society of Pediatric Surgeons. Tokyo, Japan. November 17, 2001 "Pediatric Liver Transplantation Results and Complications, UCLA Liver Transplant Program" Grand Rounds, Starship Children's Hospital. Auckland, NZ. November 17, 2001 "Issues and Controversies: Pediatric End-Stage Liver Disease Score"
"Controversies in Transplantation"
University of Colorado School of Medicin, Breckenridge, CO. March 9, 2002
"Analysis of Pre, Peri and Early Factors Affecting Outcome after Pediatric Liver Transplantation" (Abstract) American Society of Transplantation Annual Meeting. Washington, DC. April 26-May 1, 2002 "Randomized Prospective Pilot Study of CMV Hyperimmune Globulin in Prevention of Post-Transplant Lymphoproliferative Disease in Children after Liver Transplantation"(Abstract) American Society of Transplantation, Annual Meeting. Washington, DC. April 26-May 1, 2002 "The Studies of Pediatric Liver Transplantation" Pediatrics Symposium, American Society of Transplantation Annual Meeting. Washington, DC. April 26-May 1, 2002 "Prevention and Treatment of Allograft Rejection in Pediatric Liver Transplantation" European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Sicily, Italy. June 5-8, 2002 "Is Resection of Hepatoblastoma Prior to Liver Transplantation Detrimental to Outcome?" (Abstract) International Liver Transplantation Society. Chicago, IL. June 12-15, 2002 "When to Refer for Liver Transplantation" "Non-Alphabet Hepatitis" "New Aspects of Metabolic Liver Disease" "Immunosuppression After Pediatric Liver Transplantation" "Recurrent Disease After Pediatric Liver Transplantation" "Long-Term Complications after Pediatric Liver Transplantation" 24th Annual Aspen Conference in Pediatric Gastroenterology. Aspen, CO. July 22-26, 2002 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September 4, 2002 "Indications Timing and Results After Pediatric Liver Transplantation" Symposium honoring Professor Otte. Brussels, Belgium. October 4, 2002 "Post-Transplant Lymphoproliferative Disease After Pediatric Transplantation". Advances in Transplantation. San Diego, Ca. October 29, 2002 "PELD Issue and Areas of Controversy". Controversies in Tranplantation, Breckenridge , CO. March 7-9, 2003 "Analysis of Pre, Peri, and Early Post Transplant Factors and Events Effecting Suvival After Pediatric Liver Transplantation". Abstract Sue V. McDiarmid, Ravinder Anand and SPLIT Research Group. International Pediatric Transplant Association " Rio de Janerio, Brazil. April 5-9, 2003 "Studies of Pediatric Liver Transplantation 2002 Update:Demographics, Survival, Immunosuppression, Rejection". Sue V. McDiarmid, Ravinder Anand and SPLIT Research Group, International Pediatric Transplant Association Rio de Janerio, Brazil April 5-9, 2003 "Studies of Pediatric Liver Transplantation". Invited Lecture International Pediatric Transplant Association Rio de Janerio, Brazil. April 5-9, 2003 "Hepatic Transplantation Controversies and Challenges" Invited Presentation Pediatric Annual Society Annual Meeting Seattle, WA. May 4, 2003. "PELD and MELD: How The New Allocation System Has Effected Pediatric Liver Transplant Patients". Invited Lecture Digestive Disease Week 2003 Orlando, FL May 17 22, 2003. "Events on the Liver Waiting List Since PELD and MELD: Comparing Children and Adults" Abstract Sue V. McDiarmid, Ann Harper. American Transplant Congress Washington, DC, May 30-June 4, 2003. "A Multivariate Analysis of Factors Effecting Patient and Graft Survival After Pediatric Liver Transplantation" Abstract Sue V. McDiarmid, Ann Harper. American Transplant Congress Washington, DC, May 30-June 4, 2003. "Immunosuppression, Rejection and Effect on Outcome in Children after Liver Transplantation". Abstract S.V. McDiarmid, Ravinder Anand and SPLIT Research Group. International Liver Transplant Society Congress. Barcelona, Spain June 18-21 2003. "Studies of Pediatric Liver Transplant Registry" Invited Lecture National Institutes of Health Conference: Clinical Studies in Pediatric Organ Transplantation Bethesda, MD September 14-15, 2003 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September, 2003 "Controversies and Challenges in Pediatric Liver Transplantation". Grand Rounds Harbor, UCLA Torrance, CA October 30,2003. "Are too many pediatric liver recipients transplanted at Status 1? Are too many children transplanted too early". Controversies in Tranplantation. Breckenridge, CO March 5-7 2004 "Outcome of ABO Incompatible Liver Grafts in Children". Abstract American Transplant Congress Boston, MA May 14-19 2004. "Long-Term Maintenance Immunosuppression and Tolerance". Invited Lecture World Congress of Pediatric Gastroenterology, Hepatology and Nutrition . Paris, France July 3-7, 2004 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September , 2004 "Post Transplant Challenges for Pediatric Liver Patients". Invited Presentation Symposium. Chicago, ILL November 15, 2004. "Challenges in Long-Term Immunosuppression". Grand Rounds University of Wisconsin. October 7,2004 "Selection of Pediatric Candidates Under the PELD System". AASLD-ILTS Postgraduate Transplant Course. Boston, MA October 29,2004 " Post Transplant Lymphoproliferative Disease in Children". NAPTRCS Annual Meeting . January 15,2005 "Long term Immunosuppression in Children after Pediatric LiverTransplantation" Taiwanese Pediatric Surgical Society. Tapei, Taiwan March 27, 2005 "Post Transplant Lymphoproliferative Disease" "Challenges in Pediatric Liver Transplantation" Cairo, Egypt April 28,29 2005 "Pediatric Liver Transplantation" AOPO Annual Conference. June 17, 2005 "Studies of Pediatric Liver Transplantation Update". IPTA Congress, Innsbruck. August 6, 2005 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September, 2005 Disparity in Liver Transplantation in the United States. UNOS Board of Directors Strategic Planning Conference. Boston, Oct 6, 2005 "Retransplantation: Overview Of SPLIT Data". Georgia. March 7, 2006. Mowat Memorial Lecture. "Update For The Studies Of Pediatric Transplantation". London, UK. April 7,2006. "Long Term Complications After Pediatric Liver Transplantation" International Liver Transplant Society. Milan, Italy. May 3, 2006 Long Term Graft Survival: "What Factors Are Important" International Liver Transplant Society. Milan, Italy. May 5, 2006. "Membership in Professional Standards Committee Process Improvement". UNOS/OPTN Board. Richmond, VA. June, 29. 2006, "Strategic Plan For OPTN and UNOS: Identifying Challenges, Establish Goals". UNOS/OPTN Board Meeting. September 20, 2006. "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September , 2006 "Long Term Outcomes After Pediatric Liver Transplantation". Long Term Outcomes Workshop, NIH. Bethseda, MA. February 12, 2007. "Minimizing Death On The Pediatric Waiting List: Scope Of The Problem". Pediatric Summit. San Antonio. March 29, 2007. "A View From The Top Of The Trenches". Transplant Administrators Annual Meeting. Washington. DC. April 23, 2007. "Allocation Of Organs For Pediatric Recipients Workshop". American Transplant Congress. San Francisco. May 7, 2007. "Disparity In The Opportunity For Transplantation In The United States". American Transplant Patient Congress. San Francisco. May 9, 2007. "Role Of The OPTN/UNOS: The Changing Landscape Of Donation And Transplantation". Organ Procurement Organization Annual Meeting. Dallas. June 14, 2007. "Long Term Compliance Issues In Liver Transplant Recipients: Children Especially Vulnerable?" International Liver Transplantation Society. Rio De Janeiro. June 20, 2007. Vulnerability Unmasked" Presidential Address. UNOS/OPTN Board. Richmond, VA. June 26, 2007. "Who Monitors Physician Behavior And How Much". Presidential Address. UNOS/OPTN Board. Richmond,VA. June 26, 2007. "The State Of The Union".North American Transplant Coordinators Organization Annual Meeting. New York. August 15, 2006. "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September, 2007 "Is It Time To Consider Geographic Barriers In Organ Allocation" Studies Of Pediatric Liver Transplantation Annual Meeting. Nashville. October 12, 2007. "Hand Transplantation: Opening The Door To A New Era And New Debates".UCLA Ground Rounds Division of Transplantation. Los Angeles, November 27, 2007. "Transplantation: The Common Ground Between Composite Tissue Allografts And Organ Transplantation". The American Society Of Reconstructive And Microsurgery. Los Angeles. January 14, 2008. "Eastern –Western Perspective: Pediatric Liver Transplantation". The International Liver Transplantation Society. Hong Kong, China. April 5, 2008. ‘Pediatric Solid Organ Transplantation. Donation and Allocation: The Scope of the Problem. Pediatric Academic Society. May 6, 2008. "Retransplantation in the Nonadherent Young Adult. International Liver Transplantation Society". Paris, France. July 9, 2008. "Explaining good and bad outcomes in liver transplantation: can we improve adherence. World Congress of Gastroenterology and Nutrition, Brazil. August 19, 2008. "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood"UCLA Pediatric Board Review Course September 2, 2008. "Preventable Death: Children on the Transplant waiting list." Donate Life California. San Diego. November 18, 2008. "The Revolution in Pediatric Liver Disease". 25th Anniversary Symposium,
UCLA. January 30, 2009. "Update from the Studies of Pediatric Liver Transplantation". IPTA, Istanbul, Turkey. April 20, 2009. "Preventable Death: Children on the Waiting List". Alliance Pediatric Summit, Chicago. August 18-19, 2009 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood". UCLA Pediatric Board Review Course. September 9, 2009. "Immunosuppression withdrawal: Science on Russian Roulette". Denver Children's Hospital. October 1, 2009. "Pediatric Liver Transplantation: Lessons learned from a 25 year old journey". Grand Rounds. Denver Children's Hospital. October 2, 2009. "Pediatric Liver Transplantation". Baylor, Dallas. November 11, 2009 "Pediatric Liver Transplantation UCLA and Beyond. Grand Rounds, UCLA. "Withdrawal of Immunosuppression" Transplant Grand Rounds, UCLA. June 8, 2010 "Long Term Outcome after Pediatric Liver Transplantation". ILTS, Hong Kong. June 19, 2010. "Pediatric Transplantation: A Global Perspective". Transplantation Society Meeting, Vancouver. August 18, 2010. "The Essential Role of the Organ Procurement Organizations in Advancing the Field of CTA". ASRT Meeting, Chicago. November 18, 2010. "Role of Liver Transplantation for Primary Liver Tumors in Children". Transplant Grand Rounds, UCLA. February 8, 2011 "Organ Procurment and CTA". International Hand and Composite Tissue Allograft Society Meeting, Atlanta. April 7, 2011. "The Pittsburgh – UCLA Collaboration: Making Hand Transplantation a Clinical Reality". Pittsburgh. May 12, 2011. "Pediatric Autoimmune Liver Disease and Liver Transplantation". ILTS Meeting Valencia, Spain. June 24, 2011 "Minimization of Immunosuppresion". Congress of the Asian Society of Transplantation, Seoul, Korea. September 28, 2011. "Protocol for Pediatric Living Liver Donation". National University Hospital. Living Donor Symposium. Seoul. September 29, 2011. "Liver Transplantation for Pediatric Autoimmune Liver Disease". AASLD Meeting, San Francisco. November 4, 2011. ‘Split Liver Transplantation: The Pediatric Perspective' ILTS Meeting, San Francisco. May 16-19, 2012 ‘Adherence: The Risks and Consequences of Growing Up'. ILTS Meeting, San Francisco. May 16-19, 2012 ‘Neurologic Outcomes after Liver Transplantation for Acute Liver Failure' Alex Mowat Memorial Symposium, London. Septemember 7-8, 2012 SPLIT Meeting????? "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood".UCLA Pediatric Board Review Course September 5, 2012 ‘Autonomy vs Regulation' American Society of Reconstuctive Transplantation, Chicago. November 16, 2012 ‘Pediatric Liver Transplantation at UCLA: the First Quarter Century and Beyond. Grand Rounds, Bangalore, India, January 10, 2013 ‘Clinical Approach to Pediatric Cholestatic Disease. Post Graduate Course, Hyderabad, India. January 11, 2013 ‘Pediatric Liver Transplantation at UCLA: the First Quarter Century and Beyond. Grand Rounds, Irvine CA. February 15, 2013 ‘New Insights into Antibody Associated Graft Injury after Pediatric Liver Transplantation. The Role of HLA Antibody in Liver Transplantation Symposium, Dallas. March 22, 2013 '20 Years Follow up: The Pediatric Perspective'. ILTS Annual Meeting Sydney, Australia June 12, 2013 ‘Update on the Studies of Pediatric Liver Transplantation Registry'. IPTA ( International Pediatric Transplantation Association ) Meeting, Warsaw, Poland. July 15, 2013 Donor Specific HLA in Pediatric Liver Transplantation: Culprits or Innocent Bystanders. Abstract Presentation. IPTA Meeting, Warsaw, Poland. July 15, 2013 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood".UCLA Pediatric Board Review Course September 3, 2013 ‘Antibody Mediated Graft Injury after Pediatric Liver Transplantation'. SPLIT Meeting, Toronto, Canada. September 26, 2013 ‘Adolesence: Challenges and Responses'. AASLD Meeting, Boston. November 1 2013. ‘20 year Follow Up: The Pediatric Perspective' ILTS Meeting, London. June 4, 2014 ‘Pediatric to Adult Transition'. Transplantation Society of Australia and New Zealand, Canberra, Australia. June 12, 2014 ‘Hand Transplantation Outcomes: Worldwide Perspective'. Transplantation Society of Australia and New Zealand, Canberra, Australia. June 13, 2014 ‘Keep The Safe – from the Child to the Adult. World Transplant Congress, San Francisco. July 26-31, 2014 New Insights into Antibody Mediated Graft Injury after Pediatric Liver Transplantation. World Transplant Congress, San Francisco. July 26-31, 2014 "Acute and Chronic Hepatitis: Obstructive Liver Disease in Childhood".UCLA Pediatric Board Review Course September 2, 2014 ‘Regulation in Vascularized Composite Tissue Allografts'. American Society of Reconstructive Transplantation, Chicago. November 21, 2014 ‘Indications and Controversies in Pediatric Liver Transpalantation." Master Class in Liver Disease; The Practice of Living Donor Liver Transplantation. Institute of Liver Disease & Transplantation. Chennai, India. January 27, 2015 ‘Longterm Ouctomes for Pediatric Liver Transplant Recipients." Master Class in Liver Disease; The Practice of Living Donor Liver Transplantation. Institute of Liver Disease & Transplantation. Chennai, India. January 28, 2015 ‘Update on OPTN/UNOS Policy for VCAs' . Advisory Council on Organ Transplantation to the Secretary of Health. Washington DC. March 13, 2015 ‘Updates on VCA Allocation Policy'. American Organ Procurement Organization Annual Meeting. Phoenix. June 10, 2015 ‘Complications after Liver Transplantation'. Fellows' Core Curriculum Series Part 1. David Geffen School of Medicine July 10, 2015. ‘Complications after Liver Transplantation'. Fellows' Core Curriculum Series Part 2. David Geffen School of Medicine July 23, 2015 Visiting Professorships

Baylor University Medical Center at Dallas, Regional Transplant Institute September 28-29, 2004 Arnold Silverman Lectureship, Denver Children's Hospital. October 1-3, 2009

Source: https://www.grassfed.com.au/media/wysiwyg/grassfed/pdf/suzanne.pdf

G09-066 912.918

Identifying commercially relevant Echinaceaspecies by AFLP molecular markers Luigi Russi, Chiaraluce Moretti, Lorenzo Raggi, Emidio Albertini, and EgiziaFalistocco Abstract: The rising interest in medicinal plants has brought several species of the genus Echinacea to the attention ofmany scientists. Echinacea angustifolia, E. pallida, and E. purpurea are the most important for their immunological prop-erties, well known and widely used by the native Americans. The three species are easily distinguishable on the basis oftheir morphological characteristics, but it would be difficult, if not impossible, to distinguish them in commercial prepara-tions of ground, dry plant parts of E. purpurea (the most valuable species for chemotherapeutic properties) mixed with theother two species. Species-specific molecular markers could be useful to address this issue. In the present work, usingfresh material collected from cultivated Echinacea spp., AFLP analysis was used to discriminate the three species and todetect species-specific DNA fragments. By using 14 primer combinations it was possible to detect a total of 994 frag-ments, of which 565 were polymorphic. Overall, 89 fragments were unique to E. purpurea, 32 to E. angustifolia, and 26to E. pallida. E+CAC/M+AAT or E+CAC/M+AGC alone provided 13, 9, and 4 or 7, 5, and 5 specific fragments forE. purpurea, E. angustifolia, and E. pallida, respectively. A validation trial to confirm the results was carried out onbulked samples of 23 accessions covering most of the genetic diversity of the three species. The results are discussed interms of practical applications in the field of popular medicine, detecting frauds, and implications for the genus Echina-cea.

saha.org.ar2

Hipertensión Arterial Revista de Difusión de la Sociedad Argentina de Hipertensión Arterial Vol. 4 Nº 3, agosto 2015 Dirección, Consejo Editorial, Comisión Directiva Artículos de revisión Síndrome metabólico, insulinorresistenciae hipertensión arterial¿Cómo lograr el control de la presión arterial durante las 24 horas? Importancia de la cronoterapia Comentado por sus autores